Gene list
Applied filters:
COG category: Cell wall/membrane biogenesis
Gene type: CDS
Genomic element: chromosome I
Number of genes found: 172
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Vibrio fischeri ES114, ES114 >VF1394 glycine betaine transporter MSTNSKQTSDKLVPTLTIGFILLFLLAAFVDLSAFTATIQSLFMSVSTMF GYWWQWLMIITFVLAFIIAMSSYGKIKMGSESKPTIGTFRWVAMIMCTLL AGGGVFWSAAEPIFHFITPSPSFSDVKGGTLAAVAPALSQSFLHWGFLAW AVLGTLSTIVLMYAHYNCGVKLRPRALLYPILGDKLENHWIGSVIDACSI IAVAAGTIGPIGFLATQLSYSLTVLTGLESSLMSQIIILTVIVSIYSVSA FSGMDKGLQWLSRMNVIGAVALLVAILVLGPTGFIFKEFGMAFGTYIQHL PEMSLSTADPSWNSWWTWFFWGWFIGFAPMMAIFIARISQGRSIRELIIT VAIIAPIATNFWFSSLGGTGIFLELQTPGSISQPLQEAGLPAVLLASLAQ LPFSFLLIPAFLVLTTTFVATTGDSMAYSIAMAVEGTDTPSRYQRLFWAV MMGVVAGVLLIAGDGGLNALQSFIVITAVPVSFLVGVTFITGPIAVLRMK SAELESKSSVDCTKSVTV >VF0265 UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl- meso-diaminopimelate ligase MHIHILGICGTFMGGAATLARQLGHKVTGCDANVYPPMSTLLESQGIEII EGFDPSQLDPAPDLVVIGNAMSRGNPCVEYVLDKNLKYTSGPQWLQEFLL QDRWVMAVAGTHGKTTTSSMLAWVLEECGYKPGFLVGGVLGNFGESARLG ESMFFVVEADEYDSAFFDKRSKFVHYRPRTLVLNNLEFDHADIFDDLAAI QRQFHHLIRTVPSTGRIFAPKQDKPLEQVLEQGCWSELEFTGEDGQWKAI KLQKDGSQFDVYFEGENVGQVNWDLVGDHNVSNALMVVASARHVGVTPDL ACEALGKFINTKRRLELKGEVNGVTVYDDFAHHPTAIDLTLNGLRNKVGD KKIIAVLEPRSSTMKLGVHKDTLAASLHAADSVYLYQPDNIAWSVDDVAQ QCTQPAHTHNNIDAFVDMIVNEAQPGDQILVMSNGGFEGIHGKLLSGLGD AVKHIEMVD >VF2199 cell division protein FtsQ MIKAVKMNTSFDKEKVRKHLPGAIFLSLVVITSLWLVISTISWMTDEDRL PLSHMIIQGQLKHITADDIREAIDSMDSIGTFMTQDVNKLQDALLSLPWI AQVSVRKQWPETIKVFVVEHQPEATWNNRVIVNPEGVVFNAPMSDLREPK PALFGLKPAVKMYLIFGTNCKAI >VF1105 transporter MLIKLAWRNLWRQKRRTILTASALALALLLSLLMRSIQEGSYTANIENAA RLSTGLIQLQNPEFKETQSIDDLLPMSDDFIAPTKQQPNIQFTLPRIETF SLAAAKDKSKGVLVVGVDPQPENTYSSLADKVVQGAYFTATDKSVLLSEG LARYFQLNVGDEIVLYGQGYRGQTAAGLYVIKGIVHFPMPDLNNQLIYLP IQEAVQLFSTENQVTSWVLHTRDFSLLPQTVDNLQKGYGQVVSVRPWNDL SPEMEQQIQIDRVSGIIMMYILYGIVGFGLFATLLMMTLERQREFGVMLA TGMVRFRLLKLLVIESFFIGLLGILLGLVIAIPVLGYLYINPITLTGETA KAMLEMGYDPVIPVLISGWLFINQMLIVTGLLLLCLLYPLWRVYHLDIVT ALKGGSHAA >VF0184 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase MSKELIRSQIADLVDQYAALEYAPKEFVGGETVVPPSGKVLGANELKMMV EASLDGWLTTGRFNDAFEKRLGEYLGVPYVLTTTSGSSANLLALTALTSP KLGDRQLKPGDEVITVAAGFPTTVNPTIQNGLIPVFVDVDIPTYQIKPDM IEAAVTEKTKAIMVAHTLGNVFDLTEARRVADKYNLWLIEDCCDALGSTY NDQMVGTFGDISTVSFYPAHHITMGEGGAVFTKDKELRKLIESFRDWGRD CYCAPGCDDTCKKRFDQQLGSLPQGYDHKYTYSHLGYNLKITDMQAACGL AQMDRVEELVQARKDNYAYLKEGLASCEEFIILPEATENSTPSWFGFPIT IKEDSGIERVDLLKFMDQFKIGTRLLFAGNLTRQPYFKDVEYRVVGELTN TDLIMNNTFWIGVYPGLTKDHLDFVIEKFEEFFGVSF >VF2203 UDP-N-acetylmuramoylalanine--D-glutamateligase MIDTRDTPPGHDQLPENVELHSGGWQQDWLINADLIVTNPGIALASPQLK PAIDKGIKIVGDIELFAWAVNAPVIAITGSNGKSTVTDLTGEMAKAAGVK TAVGGNIGFAALDLLEQDAELYVLELSSFQLETTSTLKLKAAAFLNLSED HMDRYQGMADYRQAKLRIFEHAEVCIVNRDDKQTYPDVEKTLKSFGFDQG DYGCIEKDGIEYLAKNTVPLLAANELGLVGKHNIANSLVAIALLDAAGIN LDATLDTLRTYNGLTHRCQVVADNNGIRWVNDSKATNVASTLAALSGLQL EGKLHLLVGGVGKGADFSELSPALHDLNLMMYCFGEDGDQFVSLDPRSLL CETMNEAIATLYPTLNKGDMVMLSPACASFDQYANFMARGDAFTQLAKQY SIES >VF0195 UDP-N-acetyl-D-quinovosamine 4-epimerase MNILLTGGFGFIGQQVVKLSPIKRKVVRMGESYSGSSVHQIDTLSTTTNW QGAFTDINAIIHLAGLAHSNSFSEQDYQEVNVDGTLHLANEAAKSGVKRF VFVSSIGVNGTSTYQTPFSSLSKVEPHSAYAQSKYDAEVGLQKIAEETGL EVVIVRPTLVYGPNAPGNFGALTRLVNKVPVLPFGLVNNKRDFISVQNLA DLLITCANDPKAAGRTFLASDGQVVSIKDFTNAIAKGLNKRVIQLPIPVW CMRLAGKLLGKEVMIEQLVGNLEVDSSNAQEVLGWIPPYTMQQAMHSLLE NNK >VF0352 undecaprenyl-phosphatebeta-glucosephosphotransferase MPRSDMKQQNIKMISDSYRTLTKAFDFIAINLLLTSILSFHGLEETAVDL SAGLLFSTIFLLISEYSGLYTINTKVELKKYLLRLTFSLLLTVSVFFILK LRLASLEGMQISNLNSHIYLLWYVCVWGGLSLSRTLCTLSYTYIVIPRLK INKIAIIGLTPAGLSIEQALISKYKNQKISIEFYDDRSSSRFSYVNKSGY AGKVSELIEKVKNDEIQSVYIALPMVAKDRIKDIIHQLSNSTVNAYIVPD LYTYKLSVSQIKRIGNVHTFSIFSSPFEGLGAVIKRIEDIVIGSLITLLI LPVLCIVALGVKLSSPGPILFKQDRYGLGGKKIKVWKFRSMKVMENSEVV TQATKNDPRVTRFGSFIRRTSLDELPQFINVLQGSMSIVGPRPHAVAHNE EYRVLVDNYMVRHKIKPGITGLAQINGYRGETDTLDKMEKRVEYDIKYLQ NWSLSMDLKIIFLTVFKGFVSDTAY >VF0176 2-dehydro-3-deoxyphosphooctonate aldolase MFLIAGPCVIESEDLVLDTFAQLQEMTNKLGIEYIAKSSFTKANRSSASA FTGPGLEEGLKILQKAKDQLGVKIITDVHEDTPLDEVASVVDVLQTPAFL VRQTGFIQRVASMGKPVNIKKGQWMHPADMAPVVEKCRAVGNDDIWLCDR GTSFGFGALVNYMPGLTIMKETGCKVVMDATHSVQMPGMLNGSTGGNRLH VPAIARAAVAVGIDGLFMETHPDPDKALCDGPNMLPLKHMEELLETLLEI DEVVHRRAFIESKLV >VF0332 outer membrane protein MIKKLPLFIIVCLLAISSQALAETELEIEGLEGPLLSNVEAYISGIPEED YSVSLRFQARLQESITDALKALGYYQSTTTFVVEGDTSDRTLLVNIDAGQ PVIIYVSDIVISGEAAADEDFINAVDNSGLNLGQVINHGRYESLKSTLQN LALRKGYFDGDFTTNRLEIAPGRHQAIVRIHYDSGKRYSFGETSIDGSQI EEKRVRSIIPFQAGDPYLASQVGELNQYLSNTEWFSSVYVEPDIDAVGKT YQLPMKVHLSPQVRNQLETSIGYATDVGARGKIRWKKPWLNPEGHSLDTA LSISKPEQEATISYKIPLEQVLKDYYVVKYGLKNVDNNDTDSLESNLAFE RHWVYDSGWHRTIYTRFLYEEFTQGVQDGTAWLVLPGISFSKSRSRGGTM PMWGDKKAFTIEATDQALTSDVKLLRLQAQGAIVRSIGENHRGVARADIG AIYTDDFYKLPPSIRFFAGGDNSIRGYGYEEVSPKDSEGYLTGGQYMATA SLEYQYRVVGNWWVATFVDYGDAWLDTPDWKMGTGVGIRWASPVGPVRLD FAWGLDAEPGDEFKIHFTLGPEV >VF0131 phosphoglycerol transferase MdoB and related proteins, alkaline phosphatase superfamily MNFQQNYKQLSRAIWLSVFIAVIILSVGRLVFLANIVDTAELAQREGDLW RALFTGFRFDLKVVVIGFAPLLLIGLSVAAFPKMYRIFSKVFPWYSGLIF FLVTGFSIGNYYYYLTYGSYIDVFIFGLADDDTKAVLANAWADYPIFLSF ISSLIVACCCAAFIRTIIKKMQQWEWKTPHKITTSVSVFMMILTVFFFAR GTLGSHPLKRYHAQVSDYKVLNSITPNGIIALEWANSDYKKQNKFHTVSK AELEDQFTKVVGNTTGEFTTSKNTYLANNKPHVVMALMEGMGTNVLVEDD YPQNDLLGALRPAFESDFVFKRFLAETPATINSLVNMLGQSNVPTISHSS AQKVEVAAAAARPYKNAGYKTLFITATNGMWRNVANYLPAQGFDEILDEN AILKAFPEAEAFRGEWGLSDEYAFKLAEKELNEATQPLMIYILTITNHTP YEVPKNYDVKPLKVSKQLVERMQKGEEEAMRLLETYQYANNALGEFIANV KQSPLGDSTLIAAAGDHKLRGFTMKYPDDIAIMNAVPFYLYVPEKIQQYV PYLYDEKRVGSHKDIFPTLYAFSLSEAAYYSLGGENMLSTTDTSRFGYNP EMTVVEQGMYLNSQPEKLYQWRSELETSLEPTSNDKPNVDKDYHTLQTLY INGQVKGVH >VF0752 rare lipoprotein B precursor MTSACGFHLRGDYLLPDEVHEISLTSFDQYSSLTRDVQKQLRMNGIRQVA PTTVTPSLDLISESLNERTLSLYQNSRAAEKELTYNVSYSVLIPGHDLKT YTTTVNRNYLDNPLTALAKSVERDMIEEEMRAQAAEQILRQMARLKADDA PVETSDVITHDDETESKVTTKEVIKSMSTTAETTQ >VF0174 beta-D-GlcNAc beta-1,3-galactosyltransferase MNSYPLISVIMSVYKEEREWLVSSIQSILDQTVSDFEFIIILDFPNSELL KTLKDFEKKDSRIIIYQNEKNVGLVESLNTALSFSRGKYIARMDADDISH KNRFEKQLKYITLNNLDLVGGNVNIFHSNKGIYNTTDKVQSDYFLCKLLK IGTIGIVHPTFFSKRNVYDTIGGYYHAECAEDLELLMRANLNGFKIGNIP DVILDCRYSEKSITKENAYFMFCTVKYLKSLYRSSLKSGDYKFNSNYIEL YLYDENNKLAFSEKQNLMSEARHSFNEKKYISFLINLIKSILISRTVFFS IKVNVMSFLFRKVEVKIPKVLLACIKIKLQ >VF0166 dTDP-glucose 4,6-dehydratase MKILVTGGAGFIGSAVVRHIINNTQDSVINLDKLTYAGNLESLSDVDSDE RYVFEQVDICDGAELDRVFSEHKPDAVMHLAAESHVDRSIDGPAAFIETN IVGTYTLLEATRSYWNTLSDDKKQAFRFHHISTDEVYGDLEGTDDLFTET TSYEPSSPYSASKASSDHLVRAWLRTYGLPTIVTNCSNNYGPYHFPEKLI PLMILNALDGKSLPIYGNGMQIRDWLFVEDHARALYKVVTEGVVGETYNI GGHNEKANIDVVKTICSLLEELVPNKPEGVAQYLDLITYVTDRPGHDVRY AIDASKIERELGWKPEETFESGIRKTVEWYLDNKQWWSRVLDGSYAGERL GVYSESAVIEKEAK >VF0315 opacity associated proteins OapA MNKKKKMNVKRPDFSEQLANLKEKCGPLIEKVAPYWQRLPQFHQKALRIL VPVTFVLILLPSGAEEEVDSIQPTVIPAPEMQRQSVSLNLEGLSEQEASS NRNQRETRVNREEKVPTQTASIEKETTAVEAKWHDYQIQEGDTLYQVFRK NNLPLTELNKVVKIEGADKPLSNIKKGQLFRFKLNRQGDLDIVQIERDGQ AIMYFRMSDGNFGRSK >VF1953 outer membrane protein OmpH MILKKLVKVAALGAVLVSGSFFANAAEAATKVGYVNMAQIVQQMPQREAI SEKLRAEFKDRIDELRGLESKIKDKVETIKRDGELLGASGKTKLEREIAS LQSDYKLKAQALDEDNRRRQGEERQKLIMQVQQTVEKVANKEGYDMVVDA ATLLWAKPEDNLSEKVIKAIK >VF0134 alpha-L-glycero-D-manno-heptosebeta-1,4-glucosyl transferase MTHSSTPTLAVALIVKNEAKHLQACLETVQGWVDEIVILDSGSTDETESI ARQFTDRFFVNTEWPGFGKQRQLAQQYVTADYVLWLDADERVTPELKEDI LTAVKANKPNVAYKINRLSSAFGKFIKHSGWSPDWVVRLYKVNDMAYNDA LVHESVSVPDGVQVAPLSGRLLHFTYDVLHQYNAKNVMYIKSWVDQREGK KKGSLSGAFFHGFFCFIRMYILKRGFLDGRHGLLLAMLSASVTFNRYADL WLRDYNKSNKE >VF0374 rod shape-determining protein MreD MASSHLMRGRVIIWLSFLIALTLQAAPWPGALEVLRPSWIILVTFYWVLA LPHRVNVGTAMVLGILWDLLLGTTLGIRGMTMAILVYLVAANFKVLRNLA LWQQAAIFSGLTLLGKVLEFMGEFLVHDVSFNAHFLWAGVLNFLLWPWLF LLMRRVRRHWSIR >VF0135 ADP-heptose--LPS heptosyltransferase III MPLFTSAPHSLCILRLSAIGDVCHAIAAVQTIQTTWPSTKITWIVGKVEA QLIHDLPGITVIPFDKKLGLAGMRTIWHQLKDQQFDALVHMQLALRASLL TVGIKAKYKVGFNRKRAKEGQWLFTNRKIEDTASAHVLDSFYAFIEYLGV PKREPSWNIPLSEVDLAFIDTHVSSEKPYVVISPAASKDERNWLTERYAQ LADWLNEQGYQVVLCGSPSEREKQLGAAIESLAQSPLINIIGLTSLKQLT AVLKKATVVIAPDSGPAHIATTQHTPVIGLYGHSNPKRTGPYNSLPYVVS VYEHHVTQQQNKPIEDLKWSTRVKGDHIMQDITLDMVKEAFLRLRHQ >VF0735 alanine racemase MKFTKCALALSLALPSIANSAPLLSLDTLTNQEKIQQTNAWLEIDTQAFQ NNIDTLRASLEQDTKVCAIMKADAYGNGIEGLMASVIERNVECIGITSNE EARIVRAKGFVGELMRVRAASPNEIESGLQYKIEELIGSSEQANIIAKLA KQNNTIIPVHLALNAGGMGRNGLDLSQPQGKKEALNIAFNGHVNIVGIMT HFPNESVDEIRTKLNLFKQESQWLIDEAQLNRDDITLHVANSYTTINLPE AHLDMVRPGGLLYGDMPNNPEYKRIVQFKTSVASLNYLPKGSTIGYSSTY VLGRDSILANLPLGYSDGYVRSIGNNGYVLINGQKANVVGVTSMNTTMVD ITDIKNVQPGDEVVLFGKQNEFTIEAKEMEAFSSRSMPELYVIWGSTNPK IYK >VF1141 beta-glucosidase MDKQFKGFGLTISHVSALSGGLTNACLKVEAKEGSFVWRPISLQAKILGA DRAKEHEILQALSDESFSPNVYGENEEGILVEWLEGEVIALDKAQDVAVD LLCSVHQISLDKLSEQIKNKPMSLKDRIIDYWNSITPENQTPEMEAYFEY FSQQDEQAFFSHCLCHYDIGAYNIVVKEDGYGLIDWEYASMGDPSQDLTS MIIANQFDMDDVISLYCQKRRLNIDEWKRAVIHWTPWVTFMGALWFSLGY QLLKNTCYQELAEREMCKLIKLLPSIHK >VF0418 diacylglycerol kinase MTDVPSGKPGNTGIKRIIKATGFSIQGLKAAFKHEAAVRQEFAMLVIATP IALLLDVTVD >VF2372 glucosamine--fructose-6-phosphate aminotransferase [isomerizing] MCGIVGAVAQRDVAEILVEGLRRLEYRGYDSAGVAVVDAEHNYTRIRRLG KVKELADAVETAHVVGGTGIAHTRWATHGEPSEVNAHPHVSGDITLVHNG IIENHESLRTLLQERGYIFESQTDTEVIAHLVEWELRSSGSLLEAVQKTA TQLEGAYGTVVMDRREPERLVVARSGSPIVIGCGVGENFLASDQLALLNV TRRFMYLEEGDVAEITRREIRVFDARGEQVERAITESNAEHDAGDKGQYR HFMQKEVFEQPKALINTMEGRITNDSVVTESIGVNAVEILNKVEHVQIIA CGTSYNAGMTARYWFESLAGVSCDVEIASEFRYRKFVTRPNSLLITLSQS GETADTLAALRLAKERGYMGAMTVCNVAGSSLVRESDFAFMTRAGTEIGV ASTKAFTTQLAALLMLVTALGKQQNRISKEKEKEIVEALHALPAQIEQAL SFDKEIEALAPDFADKHHTLFLGRGEFYPIAVEASLKLKEISYIHAEAYA AGELKHGPLALIDAEMPVVVVAPTNDLLEKLKSNVEEVRARGGLLYVFAD EQAGFEADESMKIITMPHVSDITAPIYYTIPMQLLSYHVALIKGTDVDQP RNLAKAVTVE >VF1166 hypothetical protein MFNFVEPPNAFYDFENILTQDEWQKKQGWFKDKITELNSDVIGFQEVFSP NALKALVDELGYAYFCTVDEPKSEDGYVFNSPVVAFASRYPILNAQPVIA EQTQLERFGIEFEFNRIPVHASIELPHLGITDCYVVHFKSQRPKEPEVNN EIDEESLSSLNQLHNEQLGSWLSTAQRGLEANILHNHIIQQRKKTNQAIV VMGDFNKPLFHDEFKGLLSHELRFDKFSSDYLAQFQLKDSWNLYGKLKGI DLLEERTYTHYYGAKGSVLDYILLSNEFDSSFSGNILEVVDYTVTDKHIV NPTFDIDQFSTDHALVSITARIRQA >VF0186 dTDP-glucose 4,6-dehydratase MSNILMINKNDLELISDKVESSFGLFKNKNIFITGGTGFFGKWLLEAILY LNLKRNLNITVTLLSRDPERFKNNYPHLCSSDNISFIKGDVRDFPFPNEY FNYIIHAATEASSTLNKENPSLMRSTIMDGAKHICNFANTVKCERLLYTS SGAAYGPQPPNMKAMSEDFIINPNFNVNDAYSSAKLESEDFFKNNLKCQI IVARCFAFSGPYLPLDGSYAFGNFIRDALDGKNISLNGDGTAVRSYLYAA DLVIWLMKALVIGQDRTIYNIGSPDPITTLKLAEKICDASGNNSSVNVLN KSSDSGNIYIPCTLKSQSDLDVEVYTSIDESILKTLKFYR >VF1950 acyl-[acyl-carrier-protein]--UDP-N- acetylglucosamine O-acyltransferase MIHETAKIHPSAVIEGNVTIEANVSVGPFTYISGNVTIGEGTEVMSHVVI KGDTTIGKDNRIFAFAIIGEESQDKKYGGEATTVVIGDRNVIRESVQIHR GTVQDRGVTTVGSDNLLCVNVHIAHDCVVGDNIIMGNNATLAGHVTVEDF AIVSALSPVHQFCTVGAHSFIGGASVVVQDVPPFVMAQGNHCKPFGINIE GLKRRGFEKAEIHAIRRAYKALYRNGNTLEEAKVEINKEIEAFPVLQGFL DLFEKSTRGIIR >VF1556 phospholipase A1 MKKWMLLIALAIPSLSFAKELNRIHAYEDSYILGSYISDLNKQTYIDGGF EDADGLHDVEVKFKFSFAVPLFPVSQSSSIMFAYTQKSLWQLGNSDISSP FRETNYKPQFFLMHQSNMLIFNNAEFGYMHESNGQTASLSRSWDRIYGAL ERIDGPVQYGVRAWYVIADEENNEDITDYLGNYDVWASVGNDIGTLSTRF HYNFETDKGGAELGYTLNVNKFVGLYVQAWKGYGETLIDYNHDQTRIGLG IKLMPPN >VF1539 transporter MLRIFIFFITLGFGSLAFAEEAQSIDNLQQFASLIRWSGVAFSFVIVFVA WLLLRFTQSIVDGISSQFAQRRMLMQKLQSFFQFFIYMSTGMAVFMLSFR VDERVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG NYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVAVSGNYGALDMQVVIP FYIGMDQDINTARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT CKAYVVDIKFEKLFETDITLRVMQEFRKSDIFPPAIAVQNK >VF0474 D-alanyl-meso-diaminopimelate endopeptidase MFFSRYSLIALSLISFSSIADIKETLSSLPSGSRTAITVENLQSNKIEFQ QKQDELLPPASTLKIATALAARLALGTEFTFTTTLYKADKDVVLTFSGDP SLSRKQLSELFDDSELKTIQGDLWIDGSIFTGYERAVGWPWDILGVCYSA PSSALSIDENCVQASITTHEDGSTRVFVPIHQPISFSSYAKSVSREEQKS TFCDLELTTQGNHYELNGCLVRRNKPLPLKFAVQDTRDFTKRTVSKILAE HNIKLNGEIHFGAPKSELTNLNVLANHNSKPLMELLDHMLKKSDNHYADN LTKMLGHLNYQQPGSFTNGTAAIKDILLKQADIDLSNAVLVDGSGLSRNN RMTANQMKSILQFIHKYDKELGLIELLPTSGIDGTLKYRNSMRKEPIKGS MKSKSGSLFGSYNMAGFVGLENKEPQLFVQFVADYHPVVAKEGTIPVERP IDSFEKSFYQELIKLSQE >VF2207 division specific D,D-transpeptidase MKLPNRKKNNKRITKAPPTFIQWRFGVIVFFVFLALAILIARAAYIQVIE PDNLVKQGDMRSIRVKSLPSARGIISDRNDEQLAVSVPVDAVWADPVTIY KEGGLAEIERWYALADVLGLKRKELISKIEKNKKRRFIYLQRQISPAVAA YIKKLKLAGIGLKAESRRYYPTGEISAHVIGVTGIDSHGLEGVERSYDGW LTGEPGRRTVRKDRYGRVVENISLKEKQEGKPLTLSIDQRLQAIAYRAIK QAVSDFRAMSGSVVMIDIKTGEVLAMVNAPSYNPNNREQLQSFRMRNRVI TDTLEPGSTVKPFVVLAALDGGTANLDTIIDTGNGIMRIGGSRVRDSSKV GKADLTTILKKSSNIGVAHLALGMPLQELLAEYAAVGLADPSGLNLIGEA TGIFPDRRRWSDFEIATLAFGYGLSVTPIQLAHAYATLGAYGEYRPLSIL KTTGPTPGKQVVNRQHAKAVLEMMETVTQPGGTATRAAVPGYRVAAKTGT SRKAVRGGYSDEYMTVTAGVAPVSNPRIALVTIVNQPQGDEYYAGQVAAP IFGQVMKDALQILNVAPDESTVKHIDVLN >VF1481 penicillin binding protein transpeptidase MSKQKTPFRNHQFETSLFNQRVIVAFLFMLVAIGGLVFNLYHLQVRNHDR YQVRSNRNRIKIIPVAPNRGLIYDRNGVVLAQNIPVSTLELTPAKIDDIN ATLTSLQKLLNLSDHDIAKFKKLMHRTRSTKPITLIEQMSEVQIAKFSVN QFHYNGTNINAYLERYYPYGESLTHVLGYVGKINDRDIRTLKKDNRYTNY EGTHAIGKLGIELYYESTLHGKSGYQKVEINSHGRIVRTLDYVAPIPGKD IKLNIDLGLQLYAYNQLKIKKENPITHKMEDYHRRGSIVVLDPRDDSVLA MVSSPSYDPNLFVHGISSKHYNALLNNPDLPLLNRTTLGIYPPGSTVKPQ IAVAALSEKVITPNTTTNFPGWWRIPHSKSRKFRDDIRWGHGEVNVVKAI EKSVDTFFYQVAYDMGIDRLSTWMNKFGYGKPSGIDIREESPANMPTRDW KHSNYHQAWYKGDTIPVGIGQGYWTATPMQIAKATAVIADEGIVHRPHLL KSVMEDGKFKPIIFKDFPKVNHTKKQYWNLAKEGMHRVIVSGTARKLFQN LAYKAGGKTGTSQVFGLDKGEEYNSEDVAEHLRDHALFTSFAPLDKPKVL VAAVLENAGWGKYAAPIGRNIMDYVLINPKISLDHT >VF2159 serine protease MRFKPFIFSSVFLYLFSSTAVASDESRPKIGLVLAGGGAKGAAHIGVLKA LEEMHIPVDYITGTSMGAYVGGLYASGMSADEIEAFIDTVDWNSGFVDKV ERSERQIRDKEYEDRYQIGTDIGFSFTELKAPKGFVQGQTMAKILRTTSD NIPYLNSFDQLPIPFRAVATDIEKLEPVVLDKGNLAEAMMASMSVPGALP PAEYDGRLLVDGGVVNNMPVDVVREMGADIVIAVDIGSDYLEADDISSYL SVMGQLTNFMVKNSTKQQEKLLGDKDILLAPHVGKMETAEFDKMPFAYGK GYDIAYEKHKALDKLVLSDEKYQEYLKEKEIKASTLLRGEDLYVNKITIK NDSLYTESMLLDRLNLEEGRSYSADELEEHIRDLYVIDRFERVDYYYQEN EEGTHDLIVEVKEKSWGPNYLDFRFALEDDFDNQSKYSLGMSINFTDIEL TGLRDNRSELRTNFELGTDKLVSAELYTPFLVNQLLFTSFKSVYSVEQKK FSLSGNELGSIDNDFPLEYSDLVFEGAVGLQGHLWSDFRIGGRYTKGKVA FTSLRDLNASYSREGIFAQYRLDTLDNFTFPTKGFYVKAEYLYSHDNVED SVVDIEATKDSVIEISLNTRAAWTYSRHTFVGNFEYGVVENKKGDLQLEP KSLGGFLRLSGTPKDSLTGQNLIFGSLVYRYRLMDNDFGLFQSPIYLGAS LENGGLWNQDSIKDAPLYTAGSAFIGVDSPIGPIVLAYGRTEQNHESVYL SIGAVL >VF1547 aspartate racemase MNKKLGILGGMGPLATVEFMLKIISQTPAHNDQEHIPMVVSSVPQIPDRT AFIMGHGQDPYPELKHSFEQLERSGAECIVIPCNTAHYWYPQLSATSHVH TISIIDSVVQEAQNRRYKTVGLLATTATMKARMYQQKLNQYHIEVIETDD IQQRDVMQGIYEVKAGNVEKGKALMLPVFESMLAQGAEAVILGCTEIPVA LAEQNLKQPQQCLDSLEILAKCCVDWSYEEQAALAS >VF0988 hypothetical protein MSQLTATALFISSLSLLSFSSLAAEPSADDGAFSGDAKIGFIYTKTDETS MSVNSGATLKYEEALWHHKAAFSTYYTKGNESDDGTNKNKTVYDVKYDMT DSLFVFGNAKYEHDQFATYREQVLLVSGFGATLIDSSNSKLDVGAGPGYR YSKRQAFDEDLPNNSEDEVIANLFIEGDSKITDGLELGGGVRMDYGESNT TTTTHVYLKNKLMESLSLLIDAEYIYNSVVATGKEHDEIYSTISLNYDF >VF1710 outer membrane protein Slp precursor MKQVIYFLSVLLLVGCSSLPQELKSTQATTLVEYNAFSDAANAGEKAEVR LGGVIARLDNLSDQTRIEIVNLPISSVGKPDISEEPNGRFVVYVNGFIDP VTYAKGRLITVIGQADGIEQANVGEFVYPFPVIQASAIHLWQIQEYVVTN DLDMDYMPCAGARCFHQRSHLETRRGKVVQEVK >VF1246 putative omptin family serine protease MKQLIFILTPLVLISEAMAESDKKDISLGLSLGVLNGASKELVYDDTGRK LSQLDWRIDNVPIIKLETDWNINQRWTLTGDFWSILIDDGNAHMEDRDWF IENQHFPTDISISPKTTLKKAYQASLHTTYWLFIQNNYEIGALGGFQYNQ FKWEDLGGTYSYNNGTDVGTFPDVVGIDYKQEFGMFYAGLTGKYRLDNSE FSFLLKLSPWVKAKDVDNHYLRNLTFYEKSNEYSDAVSLSINYNYNFGPN MNLYTEYAYTRYFEANADMTKVNNKTNDSSFSENAAGLDNLYSTLSIGLK YSF >VF0745 D-alanyl-D-alanine serine-type carboxypeptidase MKNSAKQLKRLILSSFILGSTVAVAAPAVIPNAPQIAAKGYVLMDYHSGK VLAEKDMNVRMNPASLTKMMTSYVIGQEIESGNISMDDDVVISKNAWAKN FPGSSKMFIEVGSTVKVRELNKGIIIQSGNDACVAMAEHVAGSEDAFVDL MNAWAKTLNLKNTHFANVHGLDRDDLYSTPYDMALIGQALIRDVPEEYRV YSEKSFTYNGITQYNRNGLLWDKSMNVDGIKTGHTNGAGFNLVSSATEGK MRLVAVVMGTKSGNARKAESKKLLNYGFRFFETVSPHKANETFVTEKVWM GSTDEVALGVAEDTYVTLPRGQAKKMTASFVLEKTLEAPIYKGDVVGKLY YQIDGEDIAEYPLLALNDVEEGGIFSRLIDYIVLMFKGWLS >VF0141 UDP-bacillosamine synthetase MSKTPLVEFVRNIYQTNDFIPLHAPTFDGNEQKYVLETIQSTFVSSVGKF VDEFEQKIETYTGTAKAVATVNGTAALHAALYMAGVQHGDFVITQALTFV ATCNALHHMGAEPIFVDVSPVSLGLCPKAMDEYLTQHAQVTDTGCVHKQT KRPIRAAVPMHTFGHPVELDELIAVCHKWNITLVEDAAESLGSFYKGKHT GTLGDFGAVSFNGNKIITTGGGGMVLCKSAELGARTKHVTTTAKVPHPYE FYHDEAGFNYRMPNLNAALGCAQMEILETYLAQKKALANHYQEFFAESDF QFVVEPEYAQSNYWLNAVICPSAQARDDLLKQTNESGVMTRPIWQLMHRL PMFKDAPRGDLTQSEHIEAHLINLPSTPIAL >VF1949 lipid-A-disaccharide synthase MTKPLRIGIVAGELSGDTLGEGFIKSIKAQYPDAEFVGIGGPKMIAQGCD SLFDMEELAVMGLVEVLGRLPRLLKVKAELVRYFTQNPPDVFIGIDAPDF NLRLEKTLKDNGIKTVHYVSPSVWAWRPKRIFKIDAATDLVLAFLPFEKA FYDKYNVACEFIGHTLADAIPMETDKIAARDLLGLEQEREWLAVLPGSRG GEVALIAKPFIETCQRIHKQHPNMGFVVAAVNEKRREQFETIWKATAPEL DFVIIQDTARNVMTAADAVLLASGTVALECMLVKRPMVVGYQVNKLTGWI AQKLSITEFVSLPNVLAGKELVQEFIQEECHPDFLYPAMEKVLNNDNREL IEKFTEMHQWIRKDADKQAANAVLRLINKETAE >VF0906 outer-membrane lipoproteins carrier protein MKKFLFSLCLLSSTVLASPQSELTERLNQNAGFEAGFTQKVLSPEGDVLM QGEGDVKILRPNLFRWHTQTPDENLLVTDGNTLWYYNPFVEQVTLMGLEK ATTQTPFVLLTRNKASDWDNYSVSQNGDAFTVSPKADSAVKSEFIVRIQE NGKVTGFSVVEQDGQRSDFDFTKFEAKKPAKDNFTFAIPDGVDIDDQR >VF1411 probable lipoprotein NlpC precursor MLIPVKFIQNSYLHFLYRLVMFRHLFAIFTVVGLLGCSSTPPVAELSKQE ITTQHPQLSSSDAYQDYFYQWQGVPYKYGGTSKNGVDCSAFTQNAFDVLH RLSLPRTTEYQATSGTQIALANAKKGDLIFFKTSVKVRHVGVYIGNREFM HASTSKGVIISSLDNPYWKKAFWQVRRVL >VF1632 hypothetical outer membrane protein MACDYVQSYAVLLILWLYKVVIVSKLISRSVFCLLVLFNSSANAKISQWS LGAAAAYSPSFYKETPSNATIIPMVGYEGEHLFLRGFSGGYRLKPVGSPQ NIIFRFVYDPRTFKPNDSNDAAMQKLDERKSTVLGGMSYQMVTHIGIIEL TGGTDVGRTHNGLYAEAAWRLPIRGRGWAITPSLGYSYNSEKLNNHLYGV SNEEALRTGVDQFNADWDGQFFIGLSTYFHITPNVRVTGGLRYVNLEGNL ENSPMIEHTTSSTGSVGIVYVF >VF1104 hypothetical protein MKKKIKLIIKIVLFLAFVGVVGHVFAAEPMSADKVVAKSDEQMRGKSSYS EITMNIIRPDWTRSMSMKSWTKEQNLSLVLITGPAKDKGNASLKRDKEMW SWIPSIERVIKIAPSMLGQSWMGSDFTNDDLINQSSIVVDYDHKFVKEET IDGDKTWVIDAIAKPDAPVVWSKVRLWISQKTFIQRKVESYDEFDELVNT MTTYDIQEMGNRMIATRMVMIPADKPENKTEMITHKAQFNFLINDEFFSQ MQMKALRY >VF0175 glycosyltransferase MYKDKVAVIMSVYKSDNPIDFNVAVNSIIRQTLKCDIFIYQDGPVSRELK SAINRFRKFNNIFIFVSEENKGLAYALNYLIDSCLLNNYQYIARMDSDDI SHKNRMSIQVNFLEDNSDIHVVGSYCKEFGADCSLAEKKLPITHNDLLNF SITRCPFIHPSVMFRTSIFYNGLRYPVNTKYTEDMAFWFILLDLGYKFEN IPETLIDYRMTENTVLRRRGFDKALSEVFIRFKYMIKFKKITVKNVSFII GRFVFHLLPPNAIKYLYKKMR >VF2200 UDP-N-acetylmuramate--alanine ligase MTKEQKLQLAEIRTMIPEMRRVECIHFVGIGGAGMSGIAEVLLNEGYHIS GSDMAENTVTVRLAQKGAEIFFGHQASNVAKASVVVVSTAIDPSNPEIVA AKENRIPVIRRAEMLAELMRYRHGIAVAGTHGKTTTTALTTQIYSEAGLD PTFVNGGLVKNAGTNARLGSSRFLIAEADESDASFLHLQPMVSIVTNIEA DHMDTYGGDFETLKQTFIDFLHNLPFYGQAVMCVDDPVVRELLPQVSRQV ITYGFSDDADVRLINYRQVGQQSFFTVQRKDRTDLDIVLNIPGKHNALNA TAAIAVATEEDVEDEAILTALLNFEGAGRRFDQLGEFETGNGSAMLVDDY GHHPTEVDVTIKAARAGWAEKRLVMIFQPHRYSRTRDLYDDFANVLDNVD VLIMLDVYSAGETPIAGADGRALCRTIRGRGKIDPVFVPTIEALPPVLAN IIQEGDLILTQGAGDVGKLAKQLASMELNIETMKKLG >VF0162 putative polysaccharide export protein YccZ precursor MFMSKTHRSLASALLLVMLSGCTVFPGSHISTSDKNKVEEEQSEDNQNAY SSDINVYELTPQKVADYQVKQASAQANLELEEQVASYEYRVGPGDILNVT IWDHPELTIPAGSYRSSSESGNWVHADGTIFYPYIGTVEVEGKTVREIRT EIAQKLRKFIESPQVDVNVAAFRSKKAYVTGEVDKPGQQAITNIPLTLLD AVNRSGGLGEDADWRNVTLTRNGKEETLSLYALMQRGDLTQNRLLQSGDI IHVPRNDTQKVFVMGEVKDPKLLKMDRSGMSLTEALSSVGGINELSADAT GVFVIRSSSPDKKQESMADIYQLNIKDASALIIGTEFDLKPYDIVYVTAA PITRWNRLIMQLMPTITGFNELTEGALRVKNWP >VF0772 2-dehydro-3-deoxyphosphooctonate aldolase MQNQKTVKIGNIDVANDKPFTLFAGMNVLESRDLAMQICEKYVEVTDRLG IPYVFKASFDKANRSSVHSYRGPGMEEGLKIFQELKDTFGVKIITDIHTE AQAQPVADVVDVIQLPAFLARQTDLVEAMAKTGAVINVKKPQFMSPDQVG NIIDKFSECGNENIILCERGSCMGYDNLVVDMLGFGVMKKASNGSPIIFD VTHSLQNRDPSGKASGGRRSQTVELAKAGLATGIAGLFIEAHPNPDKALC DGPSALPLDQLEPFLKQMKSLDDLIKGFEHIDIK >VF1918 dihydrodipicolinate synthase MFSGSIVALVTPLDTDGEVDYNSLKSLVDYHIKAGTNGIVAVGTTGESAT LSVEEHVKLVMKTLEFADGRIPVIAGTGANATHEAVTFSKLFHDSGVAGC LSVTPYYNKPTQEGLFQHYKAISEATDIPQILYNVPGRTAVDLLPETVAR LAELDNIVALKDATGDLDRVAITRELCGENFIQLSGDDATALDFVKLGGH GVISVTSNIAAKDMATMFALAAQGKFEEAEIINQRLMPLHNDLFVEANPI PVKWAAHRLGMITHSDIRLPLTELSLSAQPTVEQALKSAGLLK >VF0587 membrane-bound lytic murein transglycosylase A MFRKLSFVCVLLGLAGCADQPTDRAQQYLDGGFSSNLNKVGEINSDKPSD FSAFKKQSAEVLERSESMSLRYEELYVQLQKWIDESSNPAELSNYGIQFA QMGGGDKKGNVMFTGYFSPVIEMRHTPNETFKYPVYDKPDCGSDCPTRAE INAGALAGLGLELGYADNMIDPFIMEVQGSGFVHFGDDDKLEYFAYGGKN NHPYVSIGRILIERGEVERKDMSLKAIKEWVAKNDEATVRELLETNPSYV FFSPKEAHHVLGTAGIPLHAGAAVAADRTLLPMGTPILAEVPQLDKDGKW TGKHVLKVLLALDTGGAVKENHLDQYYGMGTEAGIAAGHFKHFGRVWKLG LQDTETENPWEMPKSE >VF0138 3-deoxy-D-manno-octulosonic-acid transferase MIRLIYSLFLALLSPLLLYSLYKKKDGKPAFGRRWKEHFGCTPSLNTTQA PVWIHAVSVGEAIAAAPIIKTLKKQTPEQPILVTTTTSTGAEQIEKLGDL VEHRYMPIDFCFAVRGFLKATKPEKMLIMETELWPNTLHTVAKFGIPISV LNARLSEKSFLGYKKVQPIFNLLGKHLTHVCCQYKDDADRFVALGIQPEK VHVTGSVKFDIEITEQIQASGGILRKQLGEDRPIWIATSTHKGEDEQVLA AHRSLLHKIPNALLILVPRHPERFNSVFELCQSADFKTVKRTSNQTLTPN CQIYLGDTMGEMLTLIGASDICFMGGSLLGNKVGGHNLLEPAALAKPSIT GPSYYNFLEIAETLIKEDATKVIISAEELANLLEQLMTQPEYAEKMGKNA QSFISKNSGAVIKTLNIV >VF1751 AsmA MKKIALLISIPFIAVIGAVLVLVLLVNPNEFKPLITEQVEAQTGRQLTID GDIEWRFFPSIGFSIGKMALSNPEGFVEPNLVSFDNAILDLNVRPLFQQE VSIGLITLDGASFTLHTLKNGVTNLDGLVAKKETSTVENNNPTAPAEETD VNPEASSATSTEFNGWKVSLQGIALTNAEVLIQDDKAGSKIHFSDMNLSL SQFIPGQWAKLNFDLKGDLGKQKVALKGKTELNIAETLDDASFKNVEFNA SYADAVNKFNDITFTIDQFSFDKWANLVLKVKGKANNLEVNSNSTFALYV PKALDLIKIKEFTSTNNVKGKGIPNEDVTAVIGFNSSFALNKSFLKIDKL ALSAVDTDFTGKLSVQLNDIPKVRFDLRSPSIDVDALLATLPKDESSKTV DSTTSTKASSTPVKEVEPDLSALKTLDVAGSIIIDKFKANNAKMQNVTSV FSVNRGVLKLTKFHSDLYSGGIDMTATLDARKSVPTYSVKQTIKGVKVAP LLTDVMGESLVEGTGNIAINASGKSLKPTALKQNLKGKVSINFADGAVNG INIPLLIRTTYAKIKGEKVKGSEEAEKTDFSALTADFYLANGNATTKNIK MVSPLLRIHGEGSAHYVNETANMLIKTSIVGTLKGQGGKDIDDLKDVTIP IRVTGSWTNPKYKLEFDDVMKQKAQKEIDRGIEKLEEKYGDKIKDEKVKD AANKLLKGLFN >VF1182 acriflavin resistance periplasmic protein MFKKTAIAAVLGSILLAGCDSKEPSIAEPDSRPAKILTVSVGDHETSRLF PAKAEAGDKAVLAFRVPGQLNTLNVHAGQSVSKGELLATINPDEYRLIQK QAQAQYRLIDVQYQRIKKLRKDKVVSEQDYDTAVANRKTAKASLDQASAN LSYTKLVAPYDGTISLLPTENFEYVNAKQSIMHIQTNDILYVVFQLPDYL LQRFSFTDVSATVSFDSFPNTTFPLEFEEIDTEADRKTSSYTVKMSMPRP KDLGVLPGMSGQVKVTIPKGGSEKLPLSAIDQDGDTTYVWRVKEDGIVEK VAVKLNEKRQVVSGIEDSDQIVSSGITGLEEGMKVRKWVKERGL >VF0183 CDP-glucose 4,6-dehydratase MNPSFWKGKKVFVTGHSGFKGGWLSLWLQEMGAIVKGYSLPAPTLPSLFE EAKVGSRMSNEVGDIRDFTHLRQVISEFKPEIVFHMAAQPLVRLSYDDPM ETYSTNVMGTVYLLEAVKQVGGVKAVVNITSDKCYENREWVWGYREDEAM GGYDPYSNSKGCAELVASSYRQSFFNKDKYAEHGCALASVRAGNVIGGGD WADDRLIPDMLKAFSSNQAVEIRSPHAIRPWQHVLEPLSGYITIAEYLYE YGCDFAEGWNFGPKDEDAKPVEWIVDTLTSVWGDDARWFLSEGEHPHEAH YLKLDCSKAKMRLNWQPVWDLEYTLTKIVNWQKAWLNKQDMQQYTINEIK EYMTARAGTK >VF0168 dTDP-4-dehydrorhamnose 3,5-epimerase MDIIKTKLADCIIIKPKVFGDERGFFLETFHSQRYKEVAGIKEQFVQDNR SQSSKNVLRGLHFQKTKPQGKLVTVISGEVFDVAVDLRPESETFGQYEAV VLSGDNKLQFYVPPGFAHGFCVLSESADFQYKCTDYYDPDDESGLLWSDP IINIQWPLKTPLLSEKDKIQPLLSEIEAKIKEGWV >VF0122 Lipid A biosynthesis lauroyl acyltransferase MSKYPAPKFSSALLHPKYWGVWFGFGFLFAIVTLLPYKVTYKLGRSLGLL GLKLGKSRAHVARRNLELAFPEMESSEREAIIVENFKNSGLAIFETAMAW VWPDWRVEKHFSYENKQHILDLAEEGRGVLVVCVHALNLELTARAFTSFA PGYGVYRPHNNPAYDFIQHWGRTNNGNQMIDRKDVKGMLRVLRKGERLWY MPDHDYNRNKSVFVPFFAVPDACTTVGSDILISASKCAVVTASGFRTYNN YHLQIDNDISDQFPKKDPVGVATVMNKAVERVILRCIPQWMWLHKRFKTM EDPNVKKGIRYD >VF1869 peptidoglycan hydrolase FlgJ MQSVKMNNSVNMTDVGFIHDVGGLDKLRKSAVSGDQDSQDKALRAAAEQF ESIFTQMLFKSMRNANDSFKSDMMSSDNQQFFEQMRDDQMATELSKKGSL GLADMIVAQLGASMNQAAPVQSGNNLEQDARMAMRKAATDETLRLPADYS YPHASQAKQESQTEAPEIAQIDKMLAARKVQPADKFETPQDFVNTMKPYA EKAAKALGVDSNLLIAQAALETGWGKKVIKNSVDSSHNLFNIKADRSWQG DKISKNTLEYHDNIAVTENAAFRSYDNYEESFSDFVRFLNQNPRYERALQ QTDSSESFIKGIHSAGYATDPNYSNKVMSVMRKVESLLK >VF2233 type I secretion outer membrane protein MRKLLPLFIGMALGSFSSLAAADDLAQVYNQAKENDPQLLRAAATKDAAF EAVNSSQSSLLPQIDLTAGYNILRSDNDTRDNDRLTAGINLSQELYQQSS WVSLDIAEKSARQADSAYAAEQQGVILRVAQAYFDVLRANDNLEFVRAEK AAVARQLEQTKQRFDVGLSAITDVHDAQAQYDSVLANEVLTENQLVNSYE DLRVITGQGHTHLSVLDTKRFSASPSEQSSDSLIEEAQEKNLSLLAARIS ADVAKDNISLASSGHMPSLTFDAGYNYTDQSGTKNGFNDDSYGDINAGIN LYIPLYTGGNTSSLTSQAEFQYVAASQELEATYRDVTKNVRAFNNNINAS IGALKAYEQTVISAQSALEATEAGFDVGTRTIVDVLDSTRRLYDANRNLA NARYDYIISVLQLKQAVGTLSEQDIMDINMGLKANKTTQTK >VF1085 hypothetical protein MPPTFPSQFINENPMKKIALLLVLFSAFSNANDNISGFYLGAGLGATTFD DGGAFDYTGASINADDSTLKFMGGYQFNRIVAVELQYTKYGDINVNHPTA KAAGFKGIDIESTSISLAANLGYTFDSGWRPFGIVGLGSLESSTNVLGHS LSENNTSFHYGVGVEYAPKALSGLAFRVAYEGDMFIEENVYQDYGYYSYS DDYAMNIGTFYAGATYKF >VF0194 hypothetical protein MLSVWFGKSINVKKKIVILAEYIGENHNSTAYYWSQITKHLQGEYEIVLI APENKYSLFFASENKITTRFVKLAEHNKNNLLSRLQGQIKQTMSFLSVVK EEVGSADLLFSGTNPIVTMASLVLLKWRYRFQWLVLVHDVFPNNLIPAKV LSASSPFYKALIALSKKMYAAPDSMICIGRDMKVLLKQKIGNEKHIHYIP NWASTEKIPSLNKSDNKIITDLGWQNQVVYQFFGNMGRLQGMGNLVKAIQ QSTHQQARFLFIGCGSEADNVQKSLGQINEECGYDKTHFYGRLDLEKNHI GLNACDISLVTLSDNMCGLGVPSKAYFSMAADKPILYVGDGDSELSILLS EYPVGWACEPEQPTLLAQQLDAITENCLISEMPKMRPRVLLTEHFSEALA LTKIARVVNSTIEL >VF2326 N-acetylmuramoyl-L-alanine amidase MLIGKYFRIIWYTLFVVLSTSSFFVSANTLEGIRVWPSPDETRIVIDLNS EANYSYFTLSSPYRLVVDLKNTNVKAKLPLNVKDSKVLTKIRKSSPPSKN TTRLVFELKHSVMAEVFKLAPTPGGQYGHRLVMDLPHSKTSSSTPAPSKP SKPVINSSSNHIVGNGEIIIAIDAGHGGEDPGSIGPTRKYEKHATLAISK KVVAQINAQPGMRAVMTRSGDYFVNLNKRTEIARKNKSHLLVSIHADSFR SPQPRGGSVFVLNTRRANTEIGRWVEKHEKQSELLGGAGDVLAKNSNDRN VSQTLLDLQFSHSQKEGYKLAKNVLSEMGKVIRLHKKEPVNASLAVLKSP DIPSILIETGFISNPTEEKQLFQRAHQDKIARSISKAIIRYLHDNPPQGT LLAAQGGQTKHKVRSGESLSLIAKKYGTTMAKIKSENNLKSTSLKIGQVL VIPSNKSVYVAPKNTASSVNTSSSQARTIITHKVRSGEYLGKIASKYKVT TSSIRSLNKLKSDTLFVGQKLKVSIVAPVKKHTVKRGEFLGKIASKYGVS VSSLRKANKLRSDELAIGQVLIIPTS >VF1889 outer membrane porin protein precursor MENKFFKTTLLGAAVALASAGVTAKEVGINSDFNVEVYGVAAMSTVNYNT TGNGDGTNGYVLENESRIGFRAHKEMFENVLVTMQIESGYVDSWQGGELG ARDTYLGLSGDWGNLRAGRVLTPLYEIIDWPFSNPGLGSVFDWGGVNAHY DRQSNQVRYDSPNFGGLTFALSAGRDGNPSGSATRDSRFFSGNVKYTIST VTLMGAVEGGSDFRGVDDNDNLTYLVGAEVGLPGGFSLAGAYKQESVDKF SGKNAAGVAVSGENVDQGSFSVIGQYWLDSLGFKVGYAANLDADGIKTVG LKEESLDSNTISGQVMYVHNGFVPYLRVAGRTVGDKDTDIVTRVGLEYGF >VF1399 glycosyltransferase involved in cell wall biogenesis MNPLSIVIITLNEENRIGRLLEDLTEQTFKNFEVIVVDSNSSDATCEVAQ SFSASIPDLTVHKMDKQGVSLGRNTGASLAKHERLLFLDADVRLSPDFLT KALTQLNEKGLEVAGVYMGSKGLPVAHKLGYMTFNIGLFLTQFAFPTAVG ACIFSTRRAHKDLLGFDENITLCEDCDYVKRASRTWRFRFLPMTFEFDPR RLEQDGFLRMGYTYLKANVRRFLFGEMRNNEMEYKFGHYSNQK >VF0350 putative capsule polysaccharide export protein precursor MKPLFISFCLFLSFVSNALASEAQETPSDTQEKAKTEQSQQKEDLGYILG AGDTIQISVFKEPEMTTRLKIHRGGYVNFPYLGEIKLSGRTPTQIEEDIE ARLADGYILQPMVTVSIEAFRKFFISGEVANPNGYEFQPGLTVEQAIAMA GGFTDRSDRDSINVRSAATNELIEDVAPTYPVGPGDVVIIEQSFF >VF1329 soluble lytic murein transglycosylase MRLMKKGFVGLILGCVSNSAFAISELWLDRYAYDAIQQGFNKKDISVYHK KRGDLDNYPLSGYADYRAFLFDLENKTPEEVNQFSKKFADYPFSVSIRAD YLNALIATKNWPYLIAYQTELPRDQDYQCWYYTAFYHENELDTAFDGAKL LWLDGESVSSACNSLFSYWDKAGERTDNMILERALYAVDAKNPRLITYLR KLASTVDSKDTLTEMLRLYRQPEKFTVVFETKEDTQFNRNYAQTALKHLA KHNINSAYEKVDFVQSHFSFEVNELQATLEFLAVRLLDTKDPEIIQWRDD VFERSNDSVVLEQRIRLAIRKTEWNEIIFWINKLTSEEQASYRWQYWLAR SEMKLGDTESGETRLKRIAGNRHFYSIAASIALKREPRFPIARVECNKEQ LEPYQDDIDRVEELLALGKTYPARKHWRHVVAKENQAKSAVLACYAKKKH WHLFTHEATIRGELWDYIYLRFPVRYWKEFTRYGTKYNVDPVTLLALSRQ ESGLELTTKSPVGARGLMQVLPSTAAFMAQKYNLNYRHSSDLFDLDKNVA VGSRYLSHLLARYKNNRAYAFSAYNAGPTMVMVWRRAASKEIDIFGYIES ISFKETRVYVKNIFMFEMYYREILKLEGDFLRPSELTNSI >VF1161 periplasmic component of efflux system MKLAINKYWIYLFLFSFVVVSVGYYFVRVDSQHKKLPFVVASIGSIEKKA VAVGHIVPAHSISIKSQIDGIVGEIYHQVGEVVAINTPLIKIRPNPTPAK LMLANTDLMQSEAKLELAQKKLENLKQLVEQNIIPENYGGYIEAKSDVKS NKASVQQKKQNLDLILSGESSAGNSKLNSTIVAPINGTILNLKVEIGEPI ISTASNQAATVMMSIADMSDIIFKGSVSEHDASRLTVGTPATVILASYPD IVVSGKLRKVAVQSEKLNLTTTNTSTNSVKSFDNGFQVEVDQIQFPKNLT IRSGFSATAQIILQQSTNVIIIPERSLQFKGGEAEVWVIDDSEYGYSSRV VTLGLSDGVMVEVLSGLEEGEEIVDMSMMIGELNA >VF0373 rod shape-determining protein MreC MTPIFGRGPSLQFRLFIAVMVSASLMLADSRLNTFSDIRYLLNSFVSPIH YAANLPRTMFNGMYERFNSRNTLMLENQRLKQEMFVQNSNLLLMEQLKQE NSRLRNLLGSPFIRDEKKMVTEVMAVDSAPYTHQVMIDKGAADGVYEGQP VISDKGIVGQINNVGAHNSRVLLLTDANNAIPVQAVRNDIRVIASGKGHL DTMQLEHIPTNTDLKVGDLLVTSGLGLVYPEGYPVGYISKIDNDNKRPFA SIDIETTVEFDKLRYLLLVWPTGKAPEEISDGE >VF1106 hypothetical protein MLLKLAWRNVWRNKMRTSIMLGAMIFGVVGVILMMGFMSGFIDNMVKNTI QWQTSHIQIHQKNYALNPDINLVIDEEKEITPLLNDSSDVKAWSSRTLVN GMIASARSTRGIKINGINLQMEKKITPLSAHIIDGEWLSETGRNPILVSQ KTAERLKLRVGSKVVLTFSDTTGEVTGAAFRVSGIFKTSSSTFDDANTYV RKADLQKVGKVFQDHEIAILLNDNTKVEAFRDHLITNINSDNSVQDWLQL QPILSTMMSSMNAGNQVILVIFIVAMGFGIINILLMSVFERTREFGVLMA VGMKKDRIRYLIILESGFLGLLGGGIGVLLSILCIAVFNHTGIPLESMAQ GLNAFGIDSVLYPSISWHQYAVVSIMVFFVSVCAGLYPAHQIIKKNPVQA MAEKQ >VF0831 cell wall endopeptidase, family M23/M37 MKYKEVLAARINSLSKRHKLVLMSLSLFTVVVFIWEPTHSISQSLSEPSR STVTLSSENLQTLADQNSEPVETIFDPNDPEFNAPKDELDKHINAEDIVH SHTVDAGETLGAIFNQYALSISDMYALLDVNKSAANMRVGVDLEWQQDED GKLTELKIHRNIKDTDVYAWNGEKYTFTQIEEKGEIKPVFLSGRVTSNFY NSARSAGLTPGQIQTLAKQLQWKFDFGKEARKGDRFAVEIDKEFIDGKAV SSGDVKAVLYKNAGRDITLIKHTDGHYYDVQGRSLNRALERFPTHQRYRI SSPFNPYRKHPITGRISPHNGTDFATPVGTSVYATGDGVVVRALHHPLAG NYIIIKHGREYMTRYLHLSKILVKKGQKVSMGDKIALSGNTGRSTGPHLH YELIKNGRAVNAMKVPLPQASPVKSDERARFKQQAKLTIEALQEQV >VF1582 periplasmic component of efflux system MNKTKSIALVVLLACTLSTPSYAKKTRGNQSVAVLSEEVATHEISQSLSL IGKLKASESVVISPEVAGKIERIAVKANQNVRKGQLVVQLNDDKAIAAIK EARAYLNDEKRKLTEFQRLAKKNAITQTEIDGQKASVDIAQARLDAANAD LSDLHISAPFAGTVGFIDFSRGKMVSAGTELLTLDNLSVMQLDLQVPERY LSMLSVGMNVEATSQAWKNSVFSGKLIGVDSRINAETLNLRVRIEFPNKD LKMKPGMLMAATLDFPAINAPIIPVQALEYSGTKRYVYVVGEDNKAIRTE VTLGARVENRVVIASGLNVGDEIVVQGLVNMRDGVTVKQLEQNKTEVQ >VF0302 alanine racemase MSYMKAATAQIDMSALAHNLQKIKQQAPSSKLLAVVKANGYGHGLLNIAK GAQGADAFGVARIEEALQLRAGGIVKPILLLEGFYSAGDLPILVTNNIQT AIHCKEQLEALESTDLEFPVVAWLKVDSGMHRLGIRPEEFQEYVDRLHAC KNVAKPLRYMSHFGCADELDSSTTTEQIDTFMSLTKGCQGERSLAASAGL LAWPDSRLDWVRPGIIMYGVSPFAEQSAQELGYLPTMTLTSHLIAVRDVK AGESVGYGAIWTSERDTKIGVIAIGYGDGYPRTAPNGTPVLVNGRKVPIA GRVSMDMLTVDLGPDAQDKVGDEAILWGRDLPSEEVAEHIGTIAYELVTK LTSRVQMQYT >VF0963 peptidoglycan-associated lipoprotein MQLNKLLKSLLIALPVVALSACSSSDSATDSTAGQESTNAAETQTTNGAE GQTDTAVLSSIEADEAMNEAEVRAQAEQELRKVQTVYFAFDNSTISSEYE DMLAAHAAFLSADPSIKVTVEGHADERGTPEYNIALGERRAKAVSKYLQA LGVSADQISIVSYGEEKPLVLGQTAEDYAKNRRAVLVY >VF0139 ADP-heptose--LPS heptosyltransferase II MKILIIGPSWVGDMVMSQSLYITLKQQHPKAIIDVMAPAWCKPILDRMPE VNQAIEMPLGHGDFNLLGRRALGKELKNNNYTHAYICPNSAKSALIPWFA GVPVRTGWKGEMRYGLLNDLRPNKKAFQYMVERYVALAHPKSEMIDSSSL GGLENLPRPALSIDAKVQKNTLEKFSLSLDKPILGLCPGAEFGPAKQWPV EHYAAVANEMINRGHQVWLFGSAKDKETTESIKALVDADNQAAVFNLAGD TSLIEAVDLLAACKTVVSNDSGLMHVAAAVGCHVVGVYGSTSPKYTPPLA EKVDIVSTDIECRPCFKRDCPLGHLKCLKELKPILVLNKLL >VF0345 lipopolysaccharideN-acetylglucosaminyltransferase MKILLVNKFFFMKGGAETVYFQERDMLLSEGVKIVEFSMQHEKNIESEYS EFFVQNVDYYQKQTIKDKLATAINFIHNRQACEKLQALLEQEKPDLVHFH NIYHQLTPSIIKVAKQFGCKTVLTAHDTKIACPSYTMYRNGHTCEACVHG SVWNATKYRCQEGSLSKSVLLSLEAIYQKISKNYQYLDAIVSPSRFLGRF IQQKLPHNRIEVIVNGIDENVSLEGIKDNGYYLYLGRLSQEKGVPTLAEA HQLMTEKAGLKIVGDGPEFNQLKENYPTAELLGFKSGEELLTLIKEAKAV IVPSECYENCSMSVIEAMSYGKPVIGSKIGGIPEQIKDGIDGYLFEAGNA QALADKLDLLVKEPVKTIDMGKNARERFLSKYTLTKHKNDLLNLYQELLK G >VF0961 TolA protein MKADNNYTFAIGVSVVLHLLLVIALIFGSDFSLDDKAKPNTIQAVVIDPG TIAKQANQIRQERERAERAEQERLKKLKQQAAQLEKNRKAEEERIRRLKE KQVQEKKAARQAEEERKKAVAEAKKEKERAVAAEAERKRKADAAAKAEAA KQAKIKADKEKAAKEAAKKAQLEKERAAKAEADRKAKEKAAKAEAERKAK AEAERVAKAKAAEKARKEKAARAEAERKQKEAALNDIFAGLEDETVQNSS AKQQHIDNEVNRHAAIYTQMIQQNLLVDETYVGKSCRVKIKLASSGLLLS VTTLGGDAQVCRAAKTAVTKVNVFPMPKDADVVAKLTNINLTVQPE >VF0470 4-hydroxy-3-methylbut-2-enyl diphosphate reductase MKIVLANPRGFCAGVDRAISIVERALELYEAPIYVRHEVVHNRFVVEGLK QRGAIFVEELHEVPDDNIVIFSAHGVSQAVRKEAKERALTVFDATCPLVT KVHMEVARASKKNIEVVLIGHAGHPEVEGTMGQYASDSAGMYLVETPDDV IKLNVKDPSNLHYVSQTTLSVDETADVIDELRRVFPEIQGPRKDDICYAT QNRQDAVRDMASQVDVMIVVGSKNSSNSNRLRELSEKLGTTSYLIDCPED LKEEWLTEQTKVGVTAGASAPEELVNQIIEQVKAFGGTAVEELTGREENM FFEVPKELQIKTVS >VF0289 organic solvent tolerance protein MSFTSRSLLASFTGCLLYGTPAIADNGSEPVSPENGIVFPLQTDAVNSCE VPDKKSKEEEDQQPVLIQADSVEASNNSKAVYKGNVHIIKGRQEIKADSI TLHQQENIAIAEGNVDYSSMEMRTTSDKVTTNLSTEDTTMVNTAYKMSCQ PIRGQAGRVLKTGQEIYQLEDASFTTCPADDNSWRFKASDIELDQSDEWA TFYNARFEVLDVPIFYLPYVTVPVGDTRKTGVLIPSIGLDSKNGFELSVP IYWNIAPNYDATTTINYMERRGTQLETEFRYLTELGKGTVDAEYLNEDDK FKDKGSRWGVSWDHSGIYQQHWKFDVEYSKVSDIDYFQDLNSSIGTRDEG QLQQSGEVSYRSQDWDMTMRVRDFQVLVEEQTPYRLMPQIEFNYYAPQFY SEFDFNLHSHISKFTTDDKAKPSATRVHLEPKLSLPLSGTWWSLIPETSL LYTYYQQDFDKQPVGPNGSLNLDHEVSRTIPEVRINGAIYLDSTHKFLGE YLQTLEPKIQYLYVPEVDQSNIYGGTGDGGYDSSKLQLDYYGLFRDRQYS GVDYIADANQFSVGATSRFYDDAYKERMNISFGQILYLNGSGTEQNNDDK NSSAWAMESDFNYDDYLFYHGGIQYDSNVSELQVANSTLEYRFSKGYIQA NYRYVSKNYIESNVNFEDDLSLITQHGIYQAGLLSEYNLGRNWALKGQYF HDTKEDQMIEALVGVTYLSDCWSFGLTYSDQLIAPESAKTIGTYEPEYES NLMLSIAIRGLGNNTGITSGSANNALDYGRPFYLNN >VF0196 undecaprenyl-phosphatebeta-N-acetyl-D-fucosaminephosphotransferase MIRILDFLAAFFGLLFLWPVLLIVTIIGLFDTGSPVFIQERVGRNKKPFN LIKFRTMSVETKSVASHLASNASITKLGAFLRKTKIDELPQLINVMKGEM SLVGPRPNLFNQEELIKERDALGVYDVLPGVTGLAQVQNIDMSTPALLAK TDRKMIDTLTVKSYFQYILMTATGSGSGDAVK >VF2201 UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase MKNKNKRLLVMAGGTGGHVFPGLAVAKQLQSEGWEIRWLGTADRMEADLV PKHGIEIDFIKVKGLRGQGLKKLIAAPFQILGAISQAKKHIKAWQPDVVL GMGGYVSGPGGIAAWLSGIPVVLHEQNAVAGLTNQWLSKIAKRVFQAFPG AFPNAEVVGNPVREDVCQLPHPKERFAQRTGPIRLLVMGGSQGARILNTT LPEALPQLSHEIEIWHQAGKGSQETVEQAYRDNGIADAKVTEFIDNVAEA YAWADLLVCRSGALTVSEVSAAGVGSIFIPFMHKDRQQALNADHLVQCGA AQMIEQQDLTVQGLVDTLNGLERKQLLEMACNARDAAIIDADVRVANAIK SLAK >VF0182 glucose-1-phosphate cytidylyltransferase MKAVILAGGLGTRLSEETSVKPKPMVEIGGKPILWHIMKLYSAHGINDFI ICCGYKGYVIKEYFANYFLHMSDVTFDMKENKMEVHHKRAEPWTVTLVDT GDNSMTGGRLGRVADYLKDEEAFCFTYGDGVSDVDITKTLEFHKAHGKKA TLTATFPPGRFGALDISAGKVNSFKEKPRGDGAMINGGFFILSPKVLKLI DGDSCTWEQYPLNKLAEDGELMAYEHHGFWQPMDTLRDKVYLDELWQEGK APWKIWE >VF1917 lipoprotein-34 precursor MKVKTRFVVGSLMIAVLSACSSSPTERRQAKQDFKYLETPPLVEWQEPAD AKPEFYPQYDIPKGEFTGGIGKEVDIRPPQQVLELIPGARIEEQNGEVTV WLVKQEDVDKLWQTVLTLMKKKDIGIVKEEPSEIETDWLKWSSEDEDHEF GARYKISKLNQNNRVGFQILLIDWQVDGNQAEVTPANKARYNILMTNLVT SAYDEQLREEARIRAEELVKRIPISMGQDRSGLPVIIARAPYNIFWERLG ELLPMMGLAIEDRNRSQGTIEVKYKEPDDEFWEEIGTKPLSFDGRTYNLL LGDLGNRTSINVTDAGGKPVDEDTLDSLVPVLAAMIEKSNNAPKTEQDEE >VF1952 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase MSRITLAELAEKLDATVHGDGTVVVHSIASMSKAKEGDITFLSDAKYRKH LVECQASAVIVKEADVEFCQSNVLIMRDPYLGFALAAQALDTTPAPASDI APSAYIADDAIIGEGVAIGHNAVIESKAVIADGAMIGAGCFIGKEAKIGK NTKLWANVSVYHRVEIGEACLVQSGTVIGSDGFGYANDRGTWVKIPQLGS VIIGDNVEIGANTTIDRGAIDDTVIESNVIIDNQIQIAHNVQIGSGSAMA GGTIVAGSTKIGKHCIIGGGSVINGHIEITDGVTITGMGMVMRAIDEKGM YSSGIPLQTNKEWRKTAARVHKIDEMNKRLKAVEKKLVD >VF2574 methyltransferase GidB MTDLSQQFDRLIAQTDLNVSELQKEQLLGYVALLHKWNKAYNLTSVRNPS EMVIKHILDSIVVSPKLSGERFIDVGTGPGLPGIPLAIMNPEKSFTLLDS LGKRIRFIKQVIHELKITNVTPIQSRVEEFQPEEKFDAVLSRAFASMTDM VNWCHHLPKEEDGVFLALKGIYSEEEANDLPEWCSVKNVATLIVPELEGE RHLVTLAGKK >VF0147 acylneuraminate cytidylyltransferase MKNFAFIFARGGSKGLPGKNIKPLAGKPLLQYSVDTAIASPSIDKVFVST DDSDIAKVAVESGAILIERPAELATDISPEWLSWRHAIEWAEEYHGQFDG FVSLPATSPLRGVEDVEAAIEKRSKVGADICISITPASRSPFFNMVKETQ DGLVELVNKPESNVTRRQDAPEVFDITTVVYVTTPDFVLNNYGLFTGKVT SIEVPKVRAVDIDDIYDFRMAEAILQDAK >VF1702 membrane-bound lytic murein transglycosylase B MKKKLLLGIVSLFLATSASASATPEGDFQDYIVGLKNEAREIGISEPILE RAFKNVAFKEKAVKSDRNQPEKKLTLDEYIPRAVPKWKIKQANDLYKKHY KVLNRIGEEYGVQPRFIVALWGVESNFGKLTGGYNVIEALTTLAYDGRRE AFFKKQTMAALTILQQGHITPENMKGSWAGAMGQCQFMPTSFLSYAVDGN GDGKKDIWNTHADVFASAANYLKQVGWDDTYTWGRQVQLPESLDAESLKG LSEEKGKTLAQWQELGVRRLTGKALPDADIKAWLVQPDDKDGRAYLVYNN YQVLMDWNRSHYFALAVSHLADSIK >VF0297 acriflavin resistance periplasmic protein MKINKKYLFFPVVAVGVIVLITITKLRPDAETKPLEDRSKVVNIQLLEPQ SIAPQAIGYGKIRPKFEWKAIAEVSGKVVYRHPELHKGNILLAGTEVLRI DPLDYELKLAQAEADLGSSQTQLAKVDLEEKNIRNTLKIEKNRLSISKKE LSRKINLQKKGLTSQSDLDQQNQSYLAQQKVVQDIQNQILLLPDEKKVAA AMVKVNQAKLEEAQRSLEKTSIILPTDVRISEVDIEADQVVNLQQTMFIA HGIKTMEMEAQISIHDMQTLAQSVKAFQLSEQGMPNIDSLPLTANVELSS GRFDAKWEAKVARISETVDPNQATVGVILEIDQNYRALQPNSLPPLVNGM FVKARIEGDASEQWVIPESALHGDKIYLLGQDNKLIILPIEIVYRRNNQV AVAGDIKSHDRLILNDLLPAINGMQLRLAKSHNDEEPVQ >VF2198 cell division protein FtsQ MALTERLSWQVVLDNGIRLELGRDSREERVERFIALYKQLESKKDSIDYI DLRYDTGAAVGWKSDDVENKEEN >VF0555 TagE-like gene MPDKIRISVSHNKGTRLFAISQRRKKLVILSLVLGVSSFALSGFGLHYFY QQQESAKVAIAELQNKNNVLNQLIVDNNNSNHELTQQLEAKENELLVISQ RVDDVESVLGLQEISEEDSSLAEKTLEQRLDVAAIDSAVRATMFRLIPND TPLHYTRESSSFGRRTNPISGKRQRHLGVDLTCKRGTEIYAPADGVVELA RASNKGYGNLLKVQHSFGFMTMYAHLQKFKVRSGQFVKKGELIATCGNSG NSTGPHLHYEVRFLGRVLNPRSFMDWTPEKFDSLFEKERSVKWTPLVDVI NNVVKLQLKLTQKPTVEQVEAINTAKAENESSQQLTQ >VF2209 S-adenosyl-methyltransferase MraW MSEQFQHVSVLLHESIDGLAIKPDGIYIDGTFGRGGHSRQILSQLGENGR LYSIDRDPQAIAEAKTITDPKFTIIHGPFSGLKQYVEELDLVGKIDGVLL DLGVSSPQLDDAERGFSFMKDGPLDMRMDPTSGIPVSQWLQEADVEDITW VIREFGEDKHAWRIAKGIVAYLENEENEPLTRTSQLAKLISEVAPKSFKE KKHPATRAFQAFRIYINSELDEIDTALKGALDVLAPEGRLSVISFHSLED RMVKHFIRKESKGPQVPHGLPLTEEQIKALGSAKMKPVGKAIKPTKNEVN ENVRSRSSVLRIAERL >VF1978 accessory colonization factor AcfA-like protein MKKYLFLLMAATSTATIAAPYVGLEYGLTNMSHDYSTTFSNDNVSLTPDD SSSAFGGFVGYRFNEFGLEFGYKKFESDDSRSQMLVSDKPGYTKEREWDA DLDATQFTFKPVYFYNINEKVQLKTGLGLTYTQYKFDSSANTEYENDLTD HEFTQDYVAGDSKSESVFGGIASVGIEYMVIPNLALGASASYQVDSIANS TSFMLSSAYYF >VF1506 iron-regulated protein FrpC MKETLIPSKVEIKNIEGDAYTLNKSGVPTKVNVGQSMNADDILFTGYDAK VVVQIHGKLVTIDKNCISCLDETKSEELLQVKNIEGDIELDPTQSIDEND IAAIQDAILAGEDPTEILEATAAGESGSSANSGFVTINYAYTASIATTSF TTSNEFSYDNQDYIDSLGDGNGSNPPADPIITANNTGLTKEDEIINTDGQ LAVTNPQSNLSYTWSINGNATSEYGTLSLNAVTGEWEYILNNSALSVQSL ANGQIITDVFEVSVSAGGNLTSTQEVTVTIIGTNDDPVISGIAVGDLTEG DVGDPNPTVSDTLTVVDVDATDTHTWTILEGGSGVYGVLTINNGVWEYTL DNSRDATQALGQGDVVTETFTIEVDDGNGGTDQQEIVITINGTNDEPVIS GTNSGRVVEDLIDSAEGQLIAVDADAGDSVTWSVTDPSLGMFGSLTIDAS GKWVYSIDNNLSATQALSNGEVQTETFEVVADDGNGGTVTHTVTVEVTGT NDLPEITDTSVTTGAVEHRTTESATGDLIFEDVDALDTHTWTVEANSNDD LGTFSVDANGKWTFNLNTNSASVIALGVGETLEITYVVQVEDNHGGIDSQ EVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQLEATDADVNDTATWSV TDDAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNGEVKTETFEIVVDDGN GGTVTHTVTVEVTGINDLPEITDTSVTTGAVEHRTTESATGDLILEDVDA LDTHTWTVEANSNDDLGTFSVDADGKWTFNLNTNSASVIALGVGETLDIT YVVQVEDNHGGIDSQEVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQL EATDADVNDTATWSVTDGAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNG EVKTETFEIVVDDGNGGTVTHTVTVEVTGTNDFPEITDTSVIAGAVTEET TLTTSGDLFVDDVDTLDSHTWTLLSSNNDPYGSITVSTNPDGSGKWEYTL NNTAAQVQALANGETYTVEYQVQVDDGQGGVTTETISIEITGTNDDPIVS GQSTGLVKEDTATQSEVEGQLTVDDVDLIDVHSWSVDSNAGTYGSIVIDP ATGLWTYSIDNSLPATQALTEGESVEDKFTVTVDDGQGGTDTIEIIITVV GTNGVPIIGGDTVGEVTEDTTLTATGTLTATDEDATSSFNWNIVGSDTGT YGKFTLDASTGVWLYTLDNDAAQSLGAGDDPIKEYYTVELSDGAGGVITE TVEITINGTNDKPELSGQTLGSVKEDSIETTEGQLIVDDVDLTDTHTWSV EPATGKYGSIVVDANGKWTYTIDNSLDVTQQLAEGESGEDRFVVTVDDGQ GGTEQKEIVISLEGTNDLPSIVDSNDTGTVTEDGVQSISDTLTVEDVDLA DTHNWFVIGASESKLGHFSIDAATGEWTFVLKNDEAQLLAKDETVVESFV VVVGDGNNGYAQHTVEVTIVGTNDRPEITGRTTGTAVEDIIPTATGALTA VDVDFTDTHTWLVDGGGVGKYGTMTIDVNGNWIYTLDPSNPDTQALAENQ QEFETFTIAVDDGNGGQNAIVITVEILGTNDVPIIGGKTSQTIIEDDKAS VSGQLTDGDVDLTDTHTWTLLTDPQGIYGSMSLDANGKWTYTIDNSSPLT QGLLEGQTVKEKFIIQVEDQYGAIDTVEVTVKVKGTNDVPELSGDLSGVV EEDSAITMVNGKLEPDDKDIGDTYTWTLDSKTGSYGTLTLTADGRWVYNL DNDKASVQSLSEGERVQDTFTVTVTDGFGASTSKEIVIDIVGDNDQPSIS GATTGSTIEGTPGKDVATGELAAVDIDTLDTHTWSVVTPNGVYGSLVVDP NTGMWTYQLDNSRPATIGISSGQIVQDKFVVQVDDGQGGTSQIEVVIDIA GTNSSPGIIGDTTGEIKEDAAVNVIDGDLNSGDLDTQDTLTWEIVGSTGQ YGQFTLDQNGHWTYTLDNSNSTVNGLKEGAELVDTITVKVTDSFGEVSEK EVEITIEGTNDAPTMTGALTGTVIEDTTTVIEGQLKSGDPDVGDVHAWNL VDGVGQYGALTMNANGRWTYSLMNSLAAVQALGPSDILTEIFTVIVTDSQ GESVQKDITITIEGTNDLPEITGGTTGEYIEDVSPDVVTGQLIATDVDAG DTTTFEMRTYVGNYGTFYLEADGSWRYEINKDSAAIQSLNEGEMISETFT AVVHDSNGGFTNEQIDFTITGTNDRPVVSGDNAATVIEDAQDFLPPGETF NGQFTKVTGNVIADDIDLGDEVVSWQVINGSGVYGIFTVDENGQWTYLLD NTDPDTNALNFGDVRTEVFQITATDKHGGISEPFEVTITVEGNTDPDGGG GGSYDEVIDIDSIEEGVDGDGNAIGGGSSGTIDLPSGCEIISVDGTSSID GGLFGSLTVDNDGNWVYDVADDKSYVDSLCEGQEVTERWAVTVQTDCGTE TILVNVTITGSNDVPVIIADTDTGELGEVVEDDILEVSGQLEVVDPDSCD THTWYLVDVDGNKIGTLDPSGENIVIQGVYGELTLNQSTGEWTYVLDNDS EIVQALTPDQIEKEYVRVVVEDDKGAVSSDSTININIIGVADDAPAVAVI EEIEFKEDGSPLTQTGVLDDVAGLTPELTWNLVTGDGTYGHLTLDNNGNW TYVLDNDSLAVQQLNEGELVTDTFSVTVVDKFGKTVVDENGDPLEMIFKV DVTGTNDAPEISGQLTGTISNIDSDGRISGNLNDGDVDTGDTHTWSVADN QGDYGRLMLVNGKWTYTLDTSLDAVKLLGVGETLSDTFEVTVTDSYGETS TETITVTIDGSNLPPEIAQDDQIVMELKEDEKITDSNTLVVTDPNGDDVT FDAKTLTGTYGVFTVDENGVWTYELDNDAAHIQGLREGEVVSETFTVFAV DEHGAKTAQEVTINITGTNDVPKISGMDTASVEEADGSTASGNFVTSDVD VGDNVVVSPGTQGSYGSVSVDNNTGRWTYTVDGNDPAVNSLSKGETLTDT ITIIATDDAGDTAEMTITITINGENDAPDLVVTVPSEVTEDTDLNADGNL EVTGNWDDGDPDTADTHIWEVLSGDSLGTLTFDPNGDYKLVIDNSALEIQ QLGVGESLDLTYTVKVTDEHGLSSTQDITFTVNGTNDDPEVVDTSILSVD VEEDGIGTQTQSGQLDITDIDLNDTTFDFSVTTSPTDAYGSVTVDANGKW TYVLNNDKAQEIGDETITETFTIQIDDGNGGVITQDVTVNITGTDDDPII DTTIPQVTEGTVVEDGTLTATGQVSYVDPEGDVINYNVINPPSSPYGTFT VGADGTWTYELDNALAQEIGVAGAQETYTIEVTDQTGGTIQQVITINITG ANDDPTIDVSSVIIGSVEEDGTATAIGQLDVSDVDLTDTSFTYTVVSGPN TAATPGDVTGLYGALTVDANGEWTYLLDNDKAQALGDTVATEIFTIEVSD GNGGTVTQDITVSVTGHDDQPIVDAGATQETTGAVVEDGELHAEGTITYL DPEGTLIGYTVSTTSTPLYGTFIVDPATGKWEYDLIDSLAQAIGADGAQE SLVIDVTDATGQVTQQVITIDITGENDAPVITGTTTADVKEGVVETVSGQ LNATDAESDPIGWQISSSSSATGVYGTLSINAAGLWTYVLTENSTLALAT DTTDVFTVEASDGKGGITQQVITVAVAAPNVVQGVSGSDILTGTTNDELL FGNPLDLSDAGTADTFTWTNASIGGDLARDIIKDFDVNSDRIDLTDIANI TTVWDSATLASQIQISEVDGSTEIYINEAGSTVQTIVVDGVTLDELTGES TASMTDEEKLTSLTNSGHLVVSDTFGNEANNTLYASGQNDILTGGGGNDI FYFADEIAGSSASPAQTSIADFAVDGVAANNEADILDLAELLPDSIQASS TMDDMLQHINVNIDDSNSQTVLSVTDELGNQTDITLKGVDSTTLGISDLG SMSDQDILSTLYNDFNMFKVD >VF1799 lipid A biosynthesis (KDO) 2-(lauroyl)-lipid IVA acyltransferase MTEKIDKNVYNPTFQWAFLHPKYWPTWLGIGFAIILAFIPFRLRDKLAAK IVKLVLKKPSGGIKRAKLNIATCFPEKSEQEQQKLLEDTYITGAQVMLGF SELLVRSRKHNEKRGIFVGGENLFPLLEQKENIIILAPHAWAIDFPAILL ASRGYHVTTMMKPQKNPITDWLMHVQRMQYGGKIYARSAGIKPLIKAIKE GYLAYYLPDEDHGPQNSVFVPFFATQKATLKGFGKLARLSKAKVVPMLPS YNSETGQFEIITLPAIADFPSGDEETDARAMNIAIEQLVTERPEQYMWVL NLLRSRPGGSRLY >VF1368 membrane-bound lytic murein transglycosylase C precursor MKNVLIPFIISLATVSCTPIFDGNFQRPNSNSCNCESDITNSNNNTTSKP DSWKPSTSKPNQSIEEQLENLANHVHKTWGDKEFLEAGKHRYVKYLDGYR TRAHIDFDKGKIYVSTISQYQPKETLKKAIIGTVLMPADPSHVDLFSDKS IPLRGRPFLLGQIKDQENKDIEWPWRAGRYADYLIENKLQTKTIKNGKAY YVEISMVDDHLEQREFQYADLIKKASKEYDISIDLIYAIIQTESSFNPYA VSHAGAYGLMQVIPKTAGADVFKLVKNKPGIPTKEYLFNPAHNIDTGTAY FYILKNRYLRDIKHPTNKHYSMISAYNGGSGGVFSTFDPSRTKAIDEINS LQPNQLYWALTNKHPKAEARRYLEKVLKFQKEFNEKS >VF0340 probable transcriptional regulator SyrB MATLLTQGTLLEAKKIKKPLTKSFLLSLTILFFFCAHFFQPNPGGSGLHL AFNAASWIPASIAIAIALFHIAKQGILKFSTLSIVLFISVCLLSIPLLYQ EASPHLATGKFLGLWAGLLFFITLQQFSFSNKQKQWLLWCIIGSVLIETL FGYIQYLFLETGNSFGYNVIVNRPYGIFQQPNVMASFLVTGLAIASYFLA RQPIKYRENIIALTLLYATIIFTLPLIVVLASRTGWLSATFSLVLLVPYM WKYCTKPRFISWLLALVVGFSGSFALLDLSKNDDISNVTLISKKADLESA REYIFPQALDMFLEKPVTGYGYGNFEAEYILYTAKQHQLSSDYRAGEPSM DHPHNEILYWGVEGGIVAILGLLLAAGGVLAKIRRSKLDTQFALLALIAP IFIHSQLEYPFYHSMIHWFTFIILLFWIDQLSCKYKKYRISDISKITLRV SSLVLPIVTGFYMLSTLHTNWVLTQFETTKPMNPDILSRVTNPVVWEDRF NWDVLSTQLKIGIINKKPELIKPYIEWSQELIKTKPRPAFYQNLIIAYQA LGDEKRAEDIRREAIFLFPKSKFESVQLDKKLQMTN >VF1225 TonB protein METFVLNFRYLAAAGISLAIHTALIWSVPEKKAFAMPTGSTSSQVNIQFV APSVPTPQSVQTKKNEVTKPKEQPKQQTTVEKTVQKQVVKKKPVQSKQKP KPKKKMVKKPTISKPIEPEKKILKEKAETKPTTKTAKKTDKPVEKESTAK PVASKSGATEKPQLVQKPNFLKRPNAPRYPRIAQRKGIEGTALYEIWLNE NGKQIKQELITSSGAQVLDEAALNAIRDWQFSPQVINGQAIAHRVQIPVR FSLN >VF1795 Outer membrane protein C MKKTLLALAVPALLMAGSASAATVYTAEDGSTIDVYSRLGFNITDRNDDG DSVGNFDARIGLGGSQVVNDKVSVIGWAEYQVNAAEARGNGDWSPRYVWA GIDASEAGKVTFGRVASGIIMLSDIGDVFAASDVVLGRQLQLVDNSSAQT FRQDGTIQYQNSFGAFDMSVAYILGNTDSDQDGSYNAVGRYTFDLGDAGT LAPVLAYQANSTGDNAINPDADYTFWGAGLQYKLNALTLGAMYNQDEIEG VYSDKSTDKSYELTAVYNINDDWTARVGYRSLENSGGDEAEYKDTTFEVQ YHLTERSSIYTSYVMRDGDNGNVTTAGPVMTDWNNAEEDYYHLGLRYEF >VF2204 phospho-N-acetylmuramoyl-pentapeptide-transferase MIIWLSNFLEQYFPFFRLFEYLSFRAILSIITALTISLWMGPKLIAWLQN LQIGQVVRDDGPESHFSKRGTPTMGGIMILTAITVTVFLWADLTNPYVWA VMFVLLGYGAVGFVDDYRKVVRKNTDGLIARWKYFWQSSIALVVAFALYA YGKDTAATQLVVPFFKEVMPQLGLAYILLTYFVIVGTSNAVNLTDGLDGL AIMPTVFVAAGFAFIAWATGNVQFANYLHIPHIPLASELVVVCAAIVGAG FGFLWFNTYPAQVFMGDVGSLALGGALGTIAVLVRQEFLLVIMGGVFVVE TLSVILQVGSYKLRGQRIFRMAPIHHHYELKGWPEPRVIVRFWIISMLLV LIALATLKVR >VF2195 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase MIRQRTLKSIVQMTGVGLHSGRKVTLTLRPAAANTGVIYRRTDLNPPVDF PADPESVRDTMLCTALVNDEGVRISTVEHLNAALAGMGIDNVVIEVDAPE IPIMDGSASPFVYLLQSAGIEELNTAKKFIRIKKPVRIEDGDKWAEIRPY NGFRLDFTIDFNHPAIESDDQKLVFDFSSQSFIKDISRARTFGFMRDIEY LQSQNLCLGGSFDCAIVLDDYRILNEDGLRFDNEFVTHKVLDAVGDLYMS GHSILGELRAYKSGHALNNQLLRAVLADQEAWEWTTIEDEQESPVAFMQP GMVLA >VF1955 membrane metalloprotease MSELLWNLASFIIALGILVAVHEFGHFWVARRCGVIVEKFSIGFGKSLWS KKGKDGTEYNISMIPLGGYVKMLDERVDDVPEEQKERAFNNRPLWQRSAI VAAGPIANFLFAVFACWLAFMIGVTALKPVVGQVEDGSIFSKAGITAGVE LKAISGIQTSDWEAVSMAIVSHIGDDSMTVTYSDENNIGVEVTKRLDLSQ WNFDPEKDSPLLSLGFLPYRPALTLDVANVSSNSAAEKSGLLVGDRLVSV NGNALTKWQEMVDVIQGNPSKAVDLVISREGQTVDLVLIPDSKEIADGKV IGFAGVSPVYQEWPEGYRYEKQYGPIVAFEKALAKTGDIIDLTLTMTKKL FTGDVALNNLSGPISIAKGAGTTAEYGLVSFLGFLALISVNLGIINLLPL PVLDGGHLLFFAIEGITRKPVSERVQEIGYKVGTAMIMSLMAIALFNDFM RL >VF0755 apolipoprotein N-acyltransferase MPLLSHYFIRLLVALLSGASATLAFAPYSLWAFAFIAPLILLLLMHKQTT KKATWLGFVWGLGYFGAGVSWVHVSIDNFGGMPVAASLFLMIGLISYLSL YPMLFAFLLQRFFSNHNITKYLLAAPALWIITDWLRGWVFTGFPWLWLGY SQIDSPLSAWGPILGVEGITVMILLSVGTMAYSFIDKKWGLLLIPAVIFA TSFAIKPFDWVTPQPDKATKVALIQGNVNQAIKWLPSERWPTIMKYMDLT RKNWDADVIVWPEAAIPALEIEIPSFLRNLDSAATMNNSTVITGIVGQSP TGNFYNNIISLGVNGTNGYDYGQQPRYSKHHLLPFGEFVPFENLLRPIAP IFNLPMSSFSRGDYIQPNMEASGSHLAPALCYEIVYGEQVRENITSQTDY ILTLSNDAWFGTSIGPLQHMEMAQMRALEIGKPVIRSTNNGVTAITDHKG QITKQIPQFTTAVLRGEVIPTTGTTPYRYWGSIPLYLLVGLFLLVAWRKR KDNM >VF1455 mechanosensitive ion channel MRHFIWILLFFSSLSFASEAQDLSHLEKINAEIARLKTESNSFSGSELAI IRVQQVEKNNELRSVLSQLIQEHDKTTKELLISEVNNQIGYAERSFAYLD KELKSKQAQLDKADIEHKLALQNTLKETRDYYYLSLSDQLENYQWLADLG ESNEAQIDAFKLLIDQKIKFLSASLSFDASREQRLSDQLQHSSESEKSSL TLDHLFFERKVFNSTSGLEKLISIADQLDINTTDYKRQLFSTTGNLTEDI LKFPVIAAILSNWISSGSNWLLKHAPDQLLKFLVFILILFATRLIARLTS RVVLKAVVQPHLRMSKLMQDFFVSMSSKLIYFIGILIAFSKIGLDLAPVL TGFGVAGIIIGFALQDTLSNFASGMMLLIYRPFDVGDLVEAGSVSGKVSH MSLVNTTIKTFDNQIIILPNSMIWGDVIKNVTHERVRRVDMVFGIGYEDS IEHAEKILAEIVDAHPAALKKPEPNIRVHTLGASSVDFIVRPWVKTDDYW DVYWDITREVKLRFDKEGISIPFAQQDVHVHFAKKDKKPKKPNPITEKIG NVIDSVRSKDS >VF0766 outer-membrane lipoprotein LolB MRLSRMFPRFVRSPFTILIFTLFLNACSTTPLTPQQSTDWDKHQAKLEQI TQYKVTGKIGYQAPNQRHSLNFQWIQKPEQSQLLLTSFLGQTVMKLTMTE QMTTIETGDGQKFEGRDPGKLMYSLSGISMPIGYLQDWIKGLPTAADNFQ LNELNTVEHLSKQIGQTNWHLRYNSYIEKSNLLLPNSMKLTQQDTTIKII ASNWIISQ >VF0198 UDP-glucose 6-dehydrogenase MKIAIAGTGYVGLSNAVLLAQHNEVIAVDIMAEKVELINNKKSPISDVEI EDFLVNKKLNLTATLDKEFAYKEAEYVVIATPTDYDPVTNYFNTGSVEAV IKEVMVINPKAVMVIKSTVPVGYTERIKQELNCENIIFSPEFLREGRALF >VF0151 O-antigen ligase MINNYCQKILSSISKYWVLAIVYIPILWTLSFNFTLPNGRSIASKLLVIS AIFSFIYFRKRVFLFKEKPKTFKILITSLFIIILFRSILFLYHGEQTSSI RAFGIIFLYIYSFPYWLVKKEHIKNLTFISLFLFGLDAFIHVINNGFTRY GGNTNPNPYGLYAALIFIFVYIYNLINTKTHILYKTIPLIIIGFLPIMIS QSRGVWVSTILTLIIIHIARIKFNIKNISIYILTILAIAFSLYSTPTVKN RIEATKIEIKNIEHHNLSSSLGVRIQVWKDSIPLIKEYPFFGLGNKLKEI NNTRFENKKISQYSYYYSRNHLHSQYFEFITKQGFIGFFIIIGAIIFPLI IMRKDNDIFVKFCSISFLCVLLINFITEVPFNWINFTYTYLILILCLTLQ SYHSTKDIRS >VF2089 GTP-binding protein LepA MKHIRNFSIIAHIDHGKSTLSDRLIQVCGGLSDREMAAQVLDSMDLERER GITIKAQSVTLDYTAKDGETYQLNFIDTPGHVDFSYEVSRSLAACEGALL VVDAGQGVEAQTLANCYTAIEMDLEVVPILNKIDLPAADPDRVAEEIEEI VGIDATDATRCSAKTGLGVDEVLETIVKSIPAPEGDPEAPTQALIIDSWF DNYLGVVSLVRIKNGSLKKNDKIKVMSTGQVWGIDRIGIFTPKQIDTDVL NTGEVGWVVCGIKDILGAPVGDTLTHAKGGCEERLPGFQKVKPQVYAGLF PVSSDDYENFRDALGKLSLNDASLFYEPESSAALGFGFRCGFLGMLHMEI IQERLEREYDLDLITTAPTVVYEVAKTDGEILYVDSPAKLPAVNDIDEIR EPIARCNILVPSDYLGNVITLCVEKRGVQVDMQYHGNQVAVTYDVPMAEV VLDFFDRLKSTSRGYASLDYNFQRYEASSMVRVDVLLNGDKVDALAIITH KDNSQSRGRLLVEKMKEFIPRQMFDIAIQAAIGNHIIARSTVKQLRKNVI AKCYGGDVSRKKKLLKKQKEGKKRMKQIGNVELPQEAFLAILHVGKD >VF0475 OmpU, outer membrane protein MMNKKVLALAVAAITSAGAVNAAELYKDEAQSIEMGGRAEARLAMKDGDA ADNTRIRLNFKGTTQISDGLYGVGFWEGEFTTNDAVNPNGNLENRYTYAG IGGNFGEVTYGKNDGALGVITDFTDIMAYHGNSAAYKLAVADREDNAIAY KGQFGDFAFKANYRFDDAAANQESNDGFSTSGIYAFGDSGFKLGAGYADQ GTDNEAMVAGSMTMGDFYFAGTFTTGEVVDLDYTGFEVAGAYTMGKTVFT ATYNNADHDTNALTVANNENADNFAVDATYFFNANFRTYISYNLNLLDDD ASKGITKAMTEDEVALGMRYDF >VF0201 UDP-glucose 4-epimerase MNILVTGGMGYIGSHTCVQMIEAGLTPIILDNRYNSKEVVLDRIEALVGV KPKFYQGDIRDPKILETIFAENQIDSVIHFAGLKAVGESVEKPIMYYDNN VSGTLVLVEAMRKAGVNSIVFSSSATVYGDPASTPIREDFPTSATNPYGR SKLMVEECLTDIQKAHPEMSVTLLRYFNPVGSHKSGTMGEDPQGIPNNLM PFISQVAVGRREFLSVFGNDYPTVDGTGVRDYIHVVDLADGHLAALKYKG QEAGLHIYNLGTGNGNSVLQMVTAFEKASGAKVPYKIVDRRPGDIAECWA DPAKAREELKWEAKLSLDDMTADTWRWQSNNPEGY >VF2205 UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase MITMLLSEIAKACDGRLVGADCQISSVSTDSRHIDEEGLFVALIGERFDA HDFIPAVQEQGATALLVSKEVDTTLPQVIVSDTQKALGLVAKHVHQVCHT FTFALTGSCGKTTVKEMLASILTRSGEVLATAGNFNNEIGVPLTLLRSQP SNDFAVIELGANHQNEISYTTQLAQPNVALVNNIAAAHLEGFGSIEGVAK AKGEIFEGLQENGIAIYNLDSNGLPKWSSLFEGKQVVSFAMDDSSADFYA SNIEVNAIGEPSFQLNTPKGNIQVSLGIIGKHNVANAVAAAALAIQAHAS LNDIQQGLQELGSVKGRVAVETLASGLKVIDDTYNASVPAMKAAVDLLGG FKGQRWLVLGNMAELGEESLALHREVGEYAAPYQFEQVVTFGDDTKVISE LCNGRHFETRSDLNAYLLKELQLIKHNEVTVLVKGANSSRMSEVVSALKE CQ >VF0349 chain length regulator MALSIIENGKKLESTIDFSNFLKEFKKYRLRVLLVVLAITLAAFPLINGM TPQYTATATIVLKAKTDNSTPIDQVEDFDATQAEYYPTQAELLQSKTVIE AAAKKLDLINSPIFEDEDKDENIPQSEEEHLYSIVKAIKKKLSISPVRFS QLVHVSYESKDSDMSALVANAVVESYIEQQEQRKIEKTQQAQQWNNTRMS ELKEKIKQQKADIDKFLSDNGLLTYQGVDGFETEQLALVNDRLATAKEKR ITAKANYNTISEALGYPLEDVATLPSISNHAQLQDLRIALIQAKRTLFDL QKMYGPKNRQILEANAQIKAIELQTTALLKELKTGLYKEYQAAIERENKY RALLAEQKKDFTALAAKKDTYNTMKADLDKTQELYEKIFLRSKEQELTVL YREPVARLLDAATPPHKPSKPNKALLLIMVCAMTIIFSLLFIIIKSALNK SINNLTQVNTRLGLQGIGELISLNYIDELALFTKNFFKNSYSAETVHAIR TTILLDDKPWPIIGLTSTESTESNELNSYLLAYSFSQDRSTLLIDLDYRK EISLTEAILMQKENEIDAKKAENSDDFETVPTSTVMGVAEALEQKHPIND CLIKIENNLTFLPRGTLTETPLITLASEELGRQLKELSKQFEQVIVNLPA MTESKDAQLIARHLSGVIYTVQAGELSANHILANIEKVKQVQTPIMGVIL TDVQNDELETEEAKQQLIHQNDDILG >VF0401 UDP-N-acetylglucosamine1-carboxyvinyltransferase MYKFRIQGSDKPLSGEVTISGAKNAALPILFASLLAEEPVEVANVPKLRD VDTTMELLKRLGAEVSRNGSVHIDASGVNDFCAPYDLVKTMRASIWALGP LVARFGKGQVSLPGGCAIGARPVDLHIHGLEQLGATIKLEEGYVKAEVDG RLKGAHIVMDKVSVGATITVMCAATLAEGTTVLENAAREPEIVDTANFLN AIGAKVSGMGTDTITIEGVERLGGGYHEVVADRIETGTFLVAAAVSGGKI VCKNTKAHLLEAVLAKLEEAGADVQTGDDWISLDMTGRELKAVNIRTAPH PAFPTDMQAQFTLLNMMAKGSGIITETIFENRFMHIPELQRMGAHAEIEG NTAICGDTDGLSGAQVMATDLRASASLVIAGCIAKGETIVDRIYHIARGY DKIEDKLTALGANIERVHSDDL >VF0746 lipoprotein MRVILLAVSLILAGCASEPPQKTTDEPNAGRYQIDNDIAPDMPISVEHIE DAHPRYEPKSLYGNKDYTLLGKDYPIVKEPKGFTQEGISSWYGKKFHGHK TSNGEVYDMYSMSAAHKTLPLPSYVKVTNKDNGKTAIVRVNDRGPFHEGR IIDLSFAAAAKLDVLKTGTANVKIEYISVAKPTNPQEWHAIDPNQYHIQM VAVKNEQSADKIAKKLEAQFNAPTNIIKSGNVYRVRLGPFIDRDRADKTL IEAKNGQYTSAFIIQELKK >VF0651 amino-acid abc transporter binding protein MSRIRHHRFIQSCLVISTLLITLTGCQVESEPKTKLEQIRERGILRVSTL NNQLSYYIGSNGPTGLDYDLAKAFAEKLEVKLEITPAYTYSGLFPALERN EVDIIAANMTITPERLQKFRPGPVYYYVSQQVVYKKGSWRPRNIKNLTQL DENLTIVKDSSFEGTLIKLKEKYPNLDWNTAADTDVSELLKKVATGEIHY TLADSVELSLTQRIHPDLAVAFEVTEDQPVAWFLQQTEDDSLQALLIEFF GELKESGKLALLEEKYFGHVESFDYVDTRAFIRALESKLPKWEPLFKKYA GDFDWRFLAALSYQESHWNPLAKSPTGVRGMMMLTLPTAQSVGVKNRLNP EQVFVVVQNIYVE >VF1656 hypothetical transmembrane protein MIRLFVLCLSLMMSSTALAEDAQSIDNLQQFASLIRWSGVAASFFIILGA WLFLRFIQSIVDGVSSQFAQRRMLMQKLQSFFQFFIYMSTAVAVFMLSFR VDDRVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG HYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVTVSGNYGGLDMQVVIP FYIGMDQDINKARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT CKAYVVDIKFEKLFETDITLRVMQEFRKANIIPPTIAIQSKLA >VF1484 murein hydrolase export regulator MWVILTLIVFYSARWFAKRFPHPVNNPLLLSVCIVIPILMVLHVPYETYY ADNAFLSYLLQPAVVALAYPLYEQLPHIRANWKIILLACSVGSLFSMISG AFLAVWMGADMQLVASILPKSVTTPIAMAISSQLEGEAAIAAILVLLAGL MGAIFAYPIYNMLGIKSSLARGLTMGNVSHALGTAQAAEENPQDAAFSSL ALVICGIITSLVAPIIYSFMVMMK >VF0419 membrane-bound lytic murein transglycosylase C precursor MVKNHTQLREYKYADIVRKASLKYDIPEDLIYSIIRTESSFNPYAVSWAN AYGLMQVVPKTAGRDVFKLVKNKSGDPTPEYLFNPYNNIDTGTAYFHILK TRYLKDIRHPTSKQYSMISAYNGGAGGVFNTFSSSRSRAINDINSLQPNQ VYWALTKSTKMQRPDAT >VF0169 hypothetical protein MSKFTVFGGRGFIGSEFVKELRTQGHDVFVPEREDLSIYEDDLGTVIYSA GYGDCQRDQFNVLTANVILLSSLLQKAKFDKLVYISSTRVYMNQNESSEY SDVTICSKDNRRLFNLTKLTAEELCLKSERECLIIRPSNVYGLALNSNLF LPSIIRNAIKNKHIDMYVDKNYEKDYVSVYDVVSSTLKLIKFPQEVNKII NISSGENISANDIAQVLINKTGCSIKWKQTLNNTECFSPIDISYLKSLID YKPRTLINDINNMVDSFIESI >VF0926 sodium-type flagellar protein MotY precursor MKKIFVTSALLVSFLIATPVLANKNYVAKPEQSKWTMLENSPLECRLSHN IPNYGSAQFSSYANKKMNLDFELKMNRPMGETRAVNLVSMPARWMPGDGA ESMLNLKFFKQFDGYVGGPTAWSMLAELESGRFPTFTYADWQSPKQMIEV ALSPVLFQEQYNVFSMCIANLLPYSFEDISFTILHFDKNSDELNKASKKR LSQIADFIKYTKDVDLVLVATYTDSSGGKNVNQQVSERRALKLQNYFESI GLPADRIRVHSYGERRPIADNATPIGKNKNRRVVISLGRTII >VF1939 membrane-bound lytic murein transglycosylase D precursor MKLKLHWIGLALLAGCQTAPTPENTQPDTNSAITTPSKTEPKAAEVKPVE KPAPTPQEQEDVWQRIAMQLEMPIPDNESVDYYRNWYIKHPSHLRTVAKR AKPFLYMITVEIEKRGLPMELVLLPVVESAFDPFAYSHGSAAGLWQFVPG TADRFKLERNWWYDGRRDVPAATTAALDYMEYFDSRFDGNWQHSIASYNS GAGRVSRSIKKNQRLGKPTDFFSLDLPKETSGYVPKLLALADVIKNHEKY GVELPPIPNKPVLEMVDPKQQLDLAIAAEFAGISITELQGYNPAYNQWAT SPDGPYHLLLPIEHVDQFNANLKKNANKTMKVVRYKVQSGDTISQLAVKH NTTTKIIEQTNDLNGANIRVGQYLLIPTASKGNKTYALSAPQRLKKTQAK AKGKYKLTHKVKDGESLWSIARDNSISYRDLAKWNGMAPRDSLRVGQNLV IWKNSSDGAIIRTVHYQIRQGDNLSSIAQKFSVAVTDIMKWNNIERGSYI KPGQKLKLYVDVTKVNV >VF2108 mechanosensitive ion channel MADQGAVTDLATTGVANLEHWLTDNTELFITYGVNIISALAILFIGNIIV KKVANSVSNVLKKKKMDKAVVDFVHTLVRYLLFIIVLIAALGKVGVQTAS VVAVIGAAGLAVGLALQGSLSNFAAGVLIVAFRPFKSGDYVEIGGVAGSV DSIQIFQTILTTPDNKMVVVPNGGVIGSPITNYSRHATRRVDHVIGVSYS ADLKKTKEVITKVLESDPRVLKTPAPTVGVVALADSSVNFVVRPWCKTAE YWDVYFDTLQAIKEGLDNEGIEIPFPQMDVHLNKVD >VF0152 ADP-L-glycero-D-manno-heptose-6-epimerase MIIVTGGAGMIGSNIVKSLNNKGFNDILVVDNLKDGKKFKNLVDLDITDY MDKEDFITQIMAGDDFGPIEAIFHEGACSATTEWDGKYIMMNNYEYSKEL LHFCIEREIPFLYASSAATYGETDTFIEERAYEGALNVYGYSKQQFDNYV RRLWADAEEHNETLSQITGFRYFNVYGPREQHKGSMASVAFHLNNQMNAG DNPKLFEGSDEFKRDFVYVGDVAAVNLWFLENGVSGIYNCGTGRAEPFRA VAEAVIKHHGKGEVETIPFPEHLKGAYQEFTQADLTKLRAAGCDVEFKSV ADGVAEYMAMINK >VF2562 glucosamine-1-phosphate acetyltransferase MNFSAVILAAGKGTRMYSNKPKVLHTLAGKPMAKHVIDTCEGLGAQNIHL VYGHGGDQMKAELGEERVQWVLQAEQLGTGHAVNQAAPEFADDEKVLVLY GDVPLISAETVENLLDAQPTGGIALLTVVLDNPMGYGRIIRRNGPVIAIV EQKDATEEQKLIKEINTGVMVATGGDLKRWLAALKNENAQGEYYLTDIIA AAHDEGRAVEAVHPVSPIEVEGVNDRAQLARLERAYQAAQAQKLLEQGVM LRDPSRFDLRGTLQCGMDIEIDANVIIEGNVTLGDNVIIGAGCVLKDCEI DDNTVIRPYSVIEGATVGEECTVGPFTRLRPGAELCNDAHVGNFVEVKNV RLGEGSKANHLTYLGDAEIGKRVNVGAGVITCNYDGANKFKTIIGDDVFV GSDSQLIAPVTVANGATVGAGSTVTKDVNENELYISRAKERRIANWQRPT KK >VF0133 glycosyltransferase MKIYHINLARGFSGGEQQTLALIKQHQKQQQEIAVIALANSPFHQAVSDL GCEVITVRHYLLGHTISLPKDAVLHVHEGHAIYWAAIQHKVSQTPYIITR RLDNPIKKKWLTTFAYSNAAAIVGISTCVSEVVRTRLPQQHIVTIPDSPV IYPVNHSEVANIRERFKDKFLVIQAGNMIPHKGFDVTVNAAMRLKDPNVH LCLLGDGKQRSELEEQASGLANISFMGRQHNMGDWFAAADLLIHPSYTEG LGSVILEGMNAGLPAIGSHAGGIPDIIEHDKSGLLIEPGNSVELAENIEK IANDATLKERLIEGGREKLTSFMIEHTAALYFKVYQRALQHD >VF0140 UDP-N-acetylglucosamine 4,6-dehydratase MNSILSLIGRDTELFHQDINANEKELQSVVSQSRFLVLGGAGSIGQAVTK EIFKRNPQKLHVVDISENNMVELVRDIRSSFGYINGDFQTFALDIGSIEY DAFIKADGQYDYVLNLSALKHVRSEKDPFTLMRMIDVNVFNTDKTIQQSI DAGAKKYFCVSTDKAANPVNMMGASKRIMEMFLMRKSEEIAISTARFANV AFSDGSLLHGFNQRIQKNQPIVAPNDIKRYFVTPQESGELCLMSCIFGEN RDIFFPKLSEALHLISFADIAVKYLKQLGYEPHLCESEDEARELAKTLPA QGKWPCLFTSSDTTGEKDFEEFFTDKETLDMARFDNLGIIKNDSLYQQEL LELFEQKIGQMKTDRQWTKEEIVQLFFIMIPDFGHKETGKYLDSKM >VF0300 conserved hypothetical protein MLKKGLLTGLIAISASVHASEIDIEDADTSSSSPNSIEIDYGNDRSLSQN CSLESVYTSGTNSHVDEEKYYLSKDDCEAGTKELTLEKKPSINPVISQLE AEMEEPDTTPPSPWKSQIEFGYQSSKGNDDSQSLNGRLEASYTAGQHRHT GEVKYYLAKDDGETDKDQLSLNLQSDYKISPDYYLYANFKGLNTKYSAYF NDYTFSGGLG >VF2162 multimodular transpeptidase-transglycosylase PBP 1B MAEKKKTPTKAAPKKTAAKKKAPAKRKTSSKKKAQSSRPFWKSLMILGFK LSLVVLAILVIAGIYLDTVVKKRFDGQLFSLPTVVYSRVLTLSPGQNISL KTVQNELDLLKYQKVRQPQRPGEYSSSSTKIELIRRPFEFQQGPEPDRHV MLYFNSEGLQKIENRSVMKQMGFLQIEPQFLGMLDADDDQQRLFLRREQF PEVMVDALLATEDRDFYQHDGVSPLAIARAMVVNAKAGRTVQGGSTLTQQ LAKNLFLSRERTLWRKVREAYLALILDYRYSKDRILEAYLNEVYLGQTGG EAIHGFGLAAQVYFGRPIEELRIDQLAMLVGMVKGPSYYNPMRFPERVKE RRDLVLRLMMQEEILSPHQYEMAASRPLDVKKRATIATRQPAYFQQLKWE LKEKAGKAYQKGEGLRVFTTLDPLSQQKAEQAVERTVPQLEKRAGKGLEA AMVIVDRQSGEIRAMIGGSRTGFDGFNRAINAKRPIGSLVKPAIYLSALE TPDKFSLATTLDDKPIALKGSKGTTWTPRNFDRKFRGEVPLYYALSRSLN VPTVNLGLMVGLSKVTDTLVKLGVDANEINQVPSMLLGSINLSPYQVAQM YQTIGNGGRKAALTALKAVVDNDGNLLYENFPKSAAVVPEQATWLTVYGM KRTVSEGTARFLNSKYSWAALAGKTGTSNDSRDSWYAGIDGREVAITWLG RDDNKPMKLTGSSGALRVYADYLSMRSPEVLQLPWPNEVTAAGFDLQSNK TLEPDCSGRVKLPIWDKKGQYKAECEKNKPAAWLTDIFGF >VF1011 hypothetical protein MKKTLLALAIASISASAFAVDTSSQNSKNEDMFAFDPMHKDQFSVSGSVG VGGYYDTGSKAFYDDWATGLTLAVNYRNNRIVGYFETDLMLNYTTDNATS PILKDGSEFATDVDKAWLGFDTGFGIASFGWENDTALDAVDGAGDNTYEF GASAGDASDAFNVVKFQGSTSGFAYGVSYFETDDTHVDAEKGVNGYVGIE QEIFNVYAGYELRDEATRTLRKLPNGAKIEAVDADYQVMTVTGNVKLGEV KLGANFWIEDTSGKNLDKTNTGYYLSAGYAVTEDLTLAAGYAANTDEVTG MKDLDQSYMNVAAMYTLAKNMDMGIDIKQELDSGYNNVDEETYVFAAGYY YF >VF1388 dTDP-glucose 4,6-dehydratase MTSISVLGCGWLGLPLAKHLVDTGFMVKGSIRSSNKISELEKNHIKPYLL DIDAVEQSWSQFLTSDVLIIAIPSKNIEGFTSLIPIIEASSIKHVLFVSS TSVYEDANRVVTEEDATIPSSALSQIERLFMQSTKFTTTVIRFSGLVGYS RNPGRFFAKSGRSVSNPDVPVNMIHQDDCIGLITQIIKQEKWNEIFNACA DTHPSKREFYTQATQRIGVETPTFIESNEQTFKIISNHKIKEALGYEFIH PDVMNITYDS >VF1815 lipoprotein MKRVWISCCILLFVSACSQTPEQTEEELDTTQQIDTEYEETHVSDPLEGF NRVMWGLNYDYLDPYLVRPVSIGYVEYTPTPIRYGIANFLANLDEPSSMI NNLLMGNGNMAMVHFNRFWLNTTLGLVGLIDIASAADIQKPDSKSFGDAL GHYGVGNGPYFMLPGYGPWTLREAGDFVDGLYMPLSYLNFWQGLGKWGLE GMESRVQLISQEPMLEASPDPYVLTRDVYLQRQDFKAEIEPEVDLDAEDD IDDYLDEIDE >VF0193 UDP-2-acetamido-2,6-dideoxy-beta-L-talose2-epime rase MKKLKVMSVVGTRPEIIRLSRVLAKLDEHCEHILVHTGQNYDFELNEVFF NDLGVRKPDYFLDAAGKNAAETIGQVIIKVDQALEEILPDAMLVLGDTNS CLSAIPAKRHKVPIFHMEAGNRCFDQRVPEETNRRIVDHTADINLTYSSI ARDYLLAEGLPADRVIKTGSPMFEVLNHYMPQIDASDVLSRLGLKQGQFF VVSAHREENVDSPKQLAKLAESLNCVAEYYNLPVIVSTHPRTRNRIEAQG IEFHKNIQLLKPLGFHDYNHLQKNAKVVLSDSGTINEESSIMNFPALNLR EAHERPEGMEEASVMMVGLSVERVMQALQILESQPSGDERLLRLVYDYSM PNVSDKMVRIIHSYTDYVKRVVWKEY >VF2298 multimodular transpeptidase-transglycosylase PBP 1A MKFIKALLIVTLVCIILGVTTIFGFYQYVKPELPDVATLKDVQLQTPMQV YSRDGKLIAQFGEKRRIPLKLEEMPPHLLEAVIATEDSRFYSHYGFDPIG ITRAAFAVLASGSAKQGASTITQQLARNFFLSNEKKIMRKIKEIFIAVHI EQLLTKQEILELYLNKIYLGYRSYGVGAAAHVYFGKEVSQLTLGEVAIIA GLPKAPSTMNPIYSVDRATTRRNVVLARMLDEGYITKQEFDDAKAEVVIS KYHGAEIELQAPYIAEIARAWMVNKYGEEAAYTSGMNIYTTVDSKMQAAA NKASIDNLLAYDERHGYRGAVKTVWEPKATPLDEEAITKHLKNEPSYGEL MPAVVTSIKGKTATVDIKNNGVATIPWDGLKWARRFKTDKRQGPAPRRAS DILAVGEQIYVRPLSQETKDDVTTTVWKLSQVPAANTAFVAMDPRDGAIT SLVGGFNFVHNKFNRATQSVRQVGSSIKPFIYSAALYHGKTLASLINDAP INTWDESQGTAWRPKNSPPTYVGPARLRIGLAQSKNVMAVRVLRDVGLDE TIDYLTRFGFKKDELPRSETIALGAGSLTPVQMAQGFAVFANNGYYVEPY YIDHITGPFGDEVYKATPKTICQRDCSHQNDEDSPYAKKVISAQNAFLTK QMMYSNIWGGGSWRKGTGWNGTGWRAQVLKRRDIGGKTGTTNDSVDAWYN GYGPNVVATAWVGFDNPSHRLGYTTKNDNMTKEEMSFGGEAGGKTAIYAW VNFMKVALEGVPEEKLQLPANIIKVKIDRETGLLTNKNDETSMWEYFAGG TQPKEYVEQDFQDTIYSSHDADGDGMEDESLF >VF1954 protective surface antigen MAMKKLLIASLLFGSVAAHSAETFVIDDIRFEGLQRVALGAALLKTPVRV GDTMSQQDVAQVIQALFASGNFEDVKVFRDGNALLIKVTERPTIANISFS GNKAIKEEQMQQNLEASSIRVGEALDRTTLSNIEKGLEDFYYSVGKYNAT VHAVVTPLPRNRADLKFVFTEGVSAKIQQINFIGNEVFTDEQLLSRFNLN VDVAWWNFLADEKYQKQVLAGDIEALRSYYLDRGYLKFQVDSTQVSISPD KKGVYIALTIDEGEPYTVSGVKFQGELIGKEEEFKKLIPFENGEVYNGSA VTSLEENIKRILGEAGYAYPQVRTMPEFDDENQTVSLIINVEAGNRMYVR DIRFVGNTSTKDEVLRREMRQMEGAWLNSKSIETGKNRLNRLGFFETVDV QTVRVPGSDDEVDLVYSVKEANSGSVNFGVGYGTESGISFQVGLQQDNFI GSGNRVGINAMMNDYQKNISLDYRDPYWNLDGVSLGGKIFYNEFEASDAG IVDYTNQSYGGSLTWGFPFDELNYFEIGVGYTHNKISNLEGYVQIEQYLQ SVGDAYDSGDQTLIVSDFDVTLSWTRNNLNKGYFPTAGNYQRASYKITTP NSDSQFFKAQYEVRQYFPLTKKHEFALLMRGKAGYGNGYGQTDGNDNLYP FYENFYAGGFTTLRGFGSNSGGPKAVYAQGSNGGIGNNTSYAATDDSVGG NATALASIELIVPTPFASEETRNQIRTSVFFDMASVWDTEFDYKEPKPGM DGAQYYYDYSDPSNFRSSYGAAVQWMSPMGPLVFSIAKPVKIYEGDDEEF FSFTIGRTF >VF0468 lipoprotein signal peptidase MTSDKKTLPLLKESGLRWLWLAGIIFMADISIKLFVMKEMGYGWANRIEV LPFFNFLYVHNYGAAFSFLSDQAGWQRWFFTGIAISVCGLLVYWMRKAPQ KDKLNNIAYALIIGGAIGNVFDRLVHGFVVDYLDFYWGNYHWPAFNLADA AICIGAGLIILDGLRSGKKEQ >VF1162 outer membrane protein TolC MRDKFSEKMLFVFWALIASGLSSMSYALTIEDAWQATKQYDPEYLRSQLD EKISETTIRSSKSALLPSARITATTAWNENSTYGIALEQIIWDSSKWSEL DSSQASLLASQLKIKQSHNELAGRLISAYLDLAQSQGELRLAQQKFDEGR KMLRIVELRYKAGKIRSVDLEDMRSNHLDEEANILANRLQVEDKKVRLIK LISIEPTQVNEIKTNNLSQPKLIVNSKQEWLKLASNYSPDLLMAKQNIRI SELETGKAKTGYYPTITASVGYSDNTRSDNTRSDSGLNASLNLSLPLDLN SSIGSSVERAKLEVLRAKQDVRAVEIEIKSTISNRFNQLSLNWQRVEMAE KQVASKELVLKSKQAIYKAGMAEASDIIEAHNSLFVSKSSLQSLLYQYWR DRISLLKSVGRLDDETITLISQALQS >VF0173 hypothetical protein MIKKKKRILLVIPKFFNYEKNIKKHFELMGYDVDLIIDETPFRTILCNYI PYMKLFFGFYVENKIKKLITKNDYTSCLVIKGSSLSLKALTIIESHIKNR YLYQWDSLSNYPYQTMLLYFNHVLTFDISDSKHLNLEYYPLFSMIENDRK ELSRNIDILFIGSFHSDRYKVLKEILCQYKDLNIYFYLYIPFLSYIKRIF KGEKILLSDIRFFKIKPEKLSCFYNNSKCVLDIEAYHQTGFTMRTLEALY CGCKLITTNDNIYTADFFDKKIISVIDRNDVLLDKSFIFNDENVEDNKIL QVKNLKEWVVRFADD >VF0748 cell elongation specific D,D-transpeptidase MIKRKRTQIRDYHAETRLFASRAIISFSGIIVLIGLLLTNLYNIQINEFQ DYKTRSNDNRIKIVPIAPNRGLIFDRSGNPLAENRPVFNLEVTPDKVSDL SLLFTELQTILPITQDNIDDFQKERRRTRRFKSVPLLTQLTQEQVAIFSV NQHKFQGVEIKAYLKRFYPYGKTLTHVLGYVAKINDRDLARLAREEKDAN YQATRDIGKLGIERFYEDILHGTAGYQEVEVNSRGRVIRTLKYVPPIPGK DIVLNLDIKLQKFVEKQLDGRRGSAIVLDPKTSAVLAMVSSPSYDPNLFV HGISSKNYSALLNDPDRPLVNRSTLGIYPPASTVKPFIAVAALKEKIVTT ETTRDDPGYWRIPNSKTKPFRDWKRWGHGTVNLKQSIEESVDTFFYQIAY DMGIDRLSTWMMKFGFGDYTGIDIREESKANMPTREWKVARFRTPWYQGD TIPVGIGQGYWTATPMQLAKATAVLTNHGKVQAPHLLKGIIENNKEVPYE PEPYPPIEGVKDSYWQLAIDGMILVNNGRKGTARRAFAGTPYVSAGKSGT SQVFGLKEDEEYNADEIAEHLRDHALFTGFAPAKDPKVIISLVLENGGGG SSQGGPIARHVFDYVLLPKTEEAAKK >VF0142 UDP-N-acetylglucosamine 2-epimerase (N-acetylmannosamine-forming) MSKSLINKKVAVFTGTRAEYGLLFWLLKDIQNDPELQLQLLVSGMHLSPE FGETYQQIEADGFVINEKIEILLSSDSSVGTAKSMGLGVLGFADSLARLQ PDVLVILGDRFEALAAAQTAMIMRIPIVHLHGGEITEGAYDDAIRHAITK LSYLHGTSTEEYRQRVIQLGEDPNRVQNVGAIGLDHLKRATFMTVPELSE SLGFTLDKPFFLVTYHPVTLGNEVPEESFQALLNALDEYPDHQVILTYPN ADDGGRRIIPILEEYARNNSARVLAIPSLGQVRYLSSVMHATAVIGNSSS GIIEVPAFDVPTVNIGSRQKGRLAAKSVLNVEPNQQSISNGIQTAILRTY KLIDEKVHNPYGQGDTSGQVIEMIKSLQFTPSKAFYDITFNYVE >VF2515 glycine betaine transporter MSRNKDKYSIDNTDYTVGQDNVQKWGFDVHNPVFGISAGLIALFLVAVAV TDPESAKTVLDGFKWKIINAFDGLFMWSANIFVIFCLALIVSPFGKIRLG GDKAKPDYSMVSWIAMLFAAGMGIGLMFWGVAEPVAYFTGWFETPLGVEA NTPEAAKLALGATMFHWGLHPWAIYGVVALSLAFFAYNKGLPLSMRSIFY PILGDRTWGWPGHVVDILAVLATLFGLATSLGLGAQQAASGFHHVFGMDG GLGLQVAIIFVVTLLAVVSVMRGIDGGVKVISNINMLIAIVLLAFVALVT FAISMGTIPTTVMGYVENIIPLSNPHGRVDEAWMHGWTVFYWSWWISWSP FVGMFIARVSRGRTVREFITAVLIVPTLFTVLWMSIFGGVAIDQVVNNIG TLGSKGLTDVSLAMFEMFDALPMGNILSMIAVVLVLVFFITSSDSGSLVI DSITAGGKVDAPMPQRVFWAFMEGAIAVALLWVGGTEAIQALQAGAISTA LPFTLILLAMCVSLLMGMRTEKYNRS >VF0143 N-acetylneuraminate synthase MTLIIAEAGVNHNGDEHLAFQLVDAAYHAGADIVKFQTFKAKNLVTEDAA QAEYQVTNTQKQESQLAMLSRLELSYEVHHQLVKHCESLGIEFLSTAFDS ESLDFLVNDLGLTRLKIPSGEITNAPLVLEHARTGCDLIVSTGMATLSEI EAVLGVIAFGYVADKTAEPSELAFQQAYASEQGQKALKQKVTILHCTTEY PAPMPEINLKAMDTLGRAFELPAGYSDHSEGITIPIAAVARGAVLVEKHF TLDKNMEGPDHKASLEPQELMAMITAIRQVEVALGVGVKSPTVSEVKNKA VARKSLVVAKAIQQGEIITEDNLTIKRPGSGMSPYHYWSLLNKPASKAYQ AGDLIFE >VF0188 hypothetical protein MLLTIAIPTFNRAEKLDLQLKNICDQLIELKRDDICILVQDNHSDDQTTE ISNKYMSKFESIDFVYFRNESNLGFDRNVNLCLTNSKSKYTWILSDDDDL NSNAILTIISEIDRNVGKFNFAFINYIVRSSEGVCANKCPNIKTKLVNGM NLLYEIELSHSFISSCIFEVKSWLNKDVSEYFDSLWIHLLVARDIVPNGK TLLISEPVITMNMPSLEESRDSVIYEDKLEFYTNAHIRISKFCHELDNYG YSNDLKQYLVNKCRDYDRRQVINYKLTVERNSFKDMVRIAKAYYSVKNNT WSYFLVLLPLILLPREFFKALKWLKYVLK >VF0192 UDP-2-acetamido-2,6-dideoxy-beta-L-talose4-dehyd rogenase MKILVTGANGFIGKNLCFQLEEQGFTDLIKIDRSNSTEELNEALKSADFI YHLAGVNRPQNDDEFKLGNADLTSHIISKLKELNRTPPILLTSSIQAEQS NAYGVSKALAEDALNSYAEQSGAKVYIYRLPNVFGKWCRPNYNSVVATFC HNIVNDLPLTINDPSAKVNLVYIDTVCEHFIHHLSNNEPGGEQSIKLIYP TTVGDIATALESFKASKTSLVTENVGTGFLRALYSTYISYYSPEQFSYTI PAYTDPRGSFCELLKTKDAGQFSFFTAHPGITRGGHYHHTKNEKFLVIKG EAKFRFEHIATGECYELDVTGEDYKVVETVPGWTHDVTNIGESELVVMLW ANEIFDREKPDTFTKPL >VF1121 BCCT family transporter MKKHFELIDKPTFFGAILLLCAVVVPLLVFPAEGAEWIAVAKTFMTDKLG FAYLGLGLAAFFFMIYIVFSDIGQIKLGDPDEKPEFALASWAAMLFCGGI GASILYWGTIEWAYYYQNPPFQLEAGSEEAVRWAATYGLFHWGPIAWCIY MIPAIPIAYFFYVRKQPVLKVSAALMPVIGEANSFGKLGKVIDVLFIFGL LGGAATTLGLAAPLINEGISYLFGIPATTGSQILVLMVCTAIFAYSSYMG MDKGIKILSNINFWGALGLLLFVLVCGPTIFMLETGLDSIGRMLSNFFVM ATWAEPFGGMGTFADTHFPQDWTIFYWAWWLVFAPSMGLFVARISRGRTI KQMVSGAVFFGSLGCAMYFIILGNYGLSLQLSGELDVVGILNSEGATRAI FSVLEQLPFSTFVIAVFTLLCVIFTATTFDSISYILASVVQTNVTEDPMR WNRLFWAFTLSFMPSALMFMGGLATLQTAAIVGGLPLLVIAIMLMISGVK AAMLDLSHQDNYVDPVINISDLPDVDPWSKEGQALARFEQLRDNAIEAAD LEREANDAIWMLKKQLRKEALARGESSVDLGDAPDEIIEKLRQLTDDSTN AKEAKLAASELAQEARVAFDALMRQKVEEETLQANEEAKLAIKTRLNTPS >VF2234 D-glycero-D-manno-heptose-7-phosphate 1-kinase MKPTLPNYDQSSVLIVGDVMLDRYWGGPTSRISPEAPVPVVKVEKIEERP GGAANVAMNIAALGGDAHLVGLVGEDEPAQALTTTLESLKVHCDFVALPE FPTITKLRVMSRGQQLIRLDFEDSFHDVAAEPIISRMQQALSSVKAVVLS DYAKGALEHVQLMIQEARKVNVPVFIDPKGADFERYRGATLLTPNMLEFE TVVGKVKDEDDLVAKGQQIIEEFDFEALLVTRSEHGMTLLRRNMEPLHLP TQAREVFDVTGAGDTVISVLAASVSTGKPLDEACALANAAAGVVVGKLGT STLSTIELAEAIHGSQDSGFGIIGEEQLISAVKQARARGEKVVMTNGCFD ILHAGHVSYLNHAAELGDRLIVAVNTNESVQRLKGPGRPINPTDRRMAVL AGLGAVDWVVPFSEDTPQRLISQVLPSLLVKGGDYAIEDIAGGAEVIAAG GEVKVLNFEDGCSTTGIIEAIKGGRG >VF0165 chain length regulator (capsular polysaccharide biosynthesis) MSQAINSTRDTSTSDEIDLAKLFGQLIDGRWLILSITTLFAIAGIAFALL STPIYKADALVQVEQKSNGGMSALVGDMGEMFASESSSTTEIEIIKSRMI LGDTVDALNLTTIASPQYMPIIGKGLSRLMGEEKAIKVSRFDIPRYVDKP NFTLVLDNAEQGTYTLFDGQERKILTGKVGVLADKNDYRVFVMQLEGNTG DVFDVSKISRFDAILALQQSLSISEKGKQSGVLQFSLEGENKAQIEAIIN DVSQNYFLQNIARNSAEAEQSLEFLQAQLPAIKDKLTTSENVLNDFRLER KSVDLSLEARSALDVLVKLEAQLNELTFKESEISQRFTKDHPAYKSLIDK RKVLLAEKDRLNGQVQKLPKTQREVLRMQRDVELNQEIYIQLLNKTQELN IVKAGTVGNVRILDTAQAYTHAVKPKKPLIVVLATLLGGMLSVAIVLLKA AFHRGVENPDEIEALGIPVYASIPKSNWQEKLDIRYNKKKVKHLETLLAE SNPADLSIEALRGLRTSMHFAMMEAKNNVVMITGPAPNIGKSFVAVNFAA VIAKTGQKVLVVDADMRKGYMQRYFGMRWDNGLSDYLSGKLSLEESIQKS EVPNLDVLTRGQVPPNPSELLMTKRFSDFIDWASANYDLVLIDTPPVLAV TDPSIVGALAGTTLMVGRFDQTSVKEIDVARHRFEQAGIEVKGFILNAVE KKASSTYGYGYYNYSYDSDK >VF0883 nucleoside-diphosphate-sugar epimerase MAHRIIIVGASGYIGSQLIPLLLEQGHQVIACARNIQYLTDRVQQHPNLR CEYLDLENKTTIEPLLFDCDIGYFLVHGMSHGHDFIDYEVSLAQNFADAA EQSQLKRIIYLSALQPENHQSQHLLARQKTGEILRSTGITTIEIQSGIII GAGSAALEIMTDFINHLAIILCPKWIHSQANPIAIDNLNDYLIQCLDIEV SNSLSLEAGGPDTVTYLQLFNLLAKRLNKSIKIIPTRFISPKFAGLWLGI ITSVPSELGRALLAGIDHDLLADNSKIQQLMPQTLTPLPEALKLANHTSA NSLQGEIWGFDPSALRRWQPDYGYYPKQAGASFTTNASANSLWKVILQLG GPEGYFFANGLWRTREWLDPLLGGSFPIRRKPKSDQLQLGDYIDSWKVIR CENNEFLSLLFGMTAPGLGRLEFSIKELENNTRELDVRAWWHPKGFWGLM YWFAMFPAHLFIFKGMVKAICKKAEKEEKG >VF2433 glutamate racemase MPKHILIFDSGIGGLSVYKEIKYQLPLAKYIYAFDNAAFPYGELTESVLI ERTTHIISKLCSKFPIDIVVIACNTASTVVLPSLREKLDIPVVGVVPAIK PAALVSNKIGLLATPATVKRSYTYDLIKSFAPISDVQLLGSTRLVEMAEE KMIGIDVDITELKEILSPWQNKVDTIVLGCTHFPFLKNEIKKALGNKILL IDSGEAIARRVKQLLNGDEVESAVLFEGEVFCSAPSIKEEALNHTFKELN FSSLQCLGYPKF >VF1915 D-alanyl-D-alanine carboxypeptidase MTYQELTGQSFQHLSKLSPHRQLHHDCILPFKALSDAAHQAGFTLTIASS FRDFERQLLIWNNKFLGIRPILDDNGHELDPSSLNDLEKIHAIMRWSALP GASRHHWGTELDVYASNTLPEDVQLQLEPWEYNTGHQAEFSSWLNKNAPK FGFFFPYKTDKKGVAIEPWHISYKQNSNAYMSQLTPEMLLKAWEGVDLAG KETIIKHIDTLFVRYITNIDKE >VF2133 periplasmic component of efflux system MGKYTSAFLSYLIHRPWIISFLLFLSLFLWVMSGPSQAEESSGIKETSTF SIPLANVVIEQFESTPTHKTISLYGRTSPDKQAILGAQVAAQIEELLVKK GARVTKGQPIARLDMADLDLQLSQAKAIYSVRMKEFNAAKELKRKGLQGE VAFSQSQASLAEAKARVRNAELILENTTITAPFDGIVEHLFIEVGDFVSR GDPVAKVVVLDPLVIDVNVSERHISQITKQQKAEVSFINDVSIEGYVRYI SKISSLSTNTFSVEIEILNIGGKIPAGISSEVEINLALQSAIKVTPAMLA LNESGDLGVKTAIEAEGHSETNYKVKFVPIQLVKAEDDGVWLTGLGNEVD IITVGQGFVRDGDFIHVQRK >VF0187 hypothetical protein MVIMKNNITVCIPTFNRCESLKKTLGHLLSSKSISFSVVVSDNASEDDTW EYLNSLDDTRLIISRNETNIGFTGNILKVLELSPTDFILFMSDEDFVILE NIEEIIRTNIDDDVGVFYGGVLHENNSTYYYKYNKKTWKKKEALNKVVLS HSYMSGMIFNKKYLDLNKFNTSIADEDVVLYPHEIMVYMILCNGGKLVTD SLPIAKQGEAVESEAIIKYKYYEYNERLKLFKQYCRVVSNLDYGLIESRI FFKKMAIIASCVFVDEVLIKKIKPKQYLSEIFSLNCGWLFKLQFVTYSSA VFLMRKLKN >VF0344 glycosyltransferase MTEKITVIGTRGIPNVLGGVETHCQHLYPEIHRQFDNDICVIARSPYVDY KISSFQGVQTKAVWAPKKKSLEAIIHSTLASLTTLFDGSKVIHVHAIGPG LVVPLLRLLGKKVVFTHHGPDYDRQKWGGFAKRILKLGEKLAATYANEII VISEVINDIIKEKYNRYDAHLIYNGVKLPTQLPQEKIDSTLSKFALTAGN YFVAVGRFVEEKGFHDLIDAYQQANLNIPLVIMGDTDHPTPYSEKLKQQA KNVDGVILTGFLKGEELQAIFSQAKTFVMPSYHEGLPIALLEAMSYSLPA IVSNIPANLEVKLTPDTYFSIGNTEELTLQLAQHAKNEYSSINYASYLEY YDWEKIATQTMAVYQRALTKKVLSGQS >VF1280 carboxy-terminal processing protease precursor MNCRFRVSLIAAGVMLAASAHALEAKVLDAKFSETDLPVLAAETQHATAS KRVTSRFTRSHYKHFSLDDDFSVAIYERYLDMLDYNRNVFIQADLASFAP LSTQLDDQLKVGDTKAAFDIYNLSLKRRFERYVYALSLLDKEFDYTVDES IELDRSEAAWPKDEAELNELWRKRVKYDALNLSMAGKDWPEIQEMLGKRY NNALKRLTQSHNEDAFQLYINAFAREVDPHTSYLSPRNAEQFQSEMNLSL EGIGAVLQATDDYTVIRSLVAGGPALTSKKLSEGDRIIGVGQEGEKIVDV IGWRLDDVVQLIKGPKGTKVKLEILPEGKDSKSHTVTIVRDKIRLEDRAV KSEVIEQNGKKIGVLEVPSFYVGLAEDTKKEIAELKEKDISGIIVDLRNN GGGALTEATALSGLFITAGPVVQVRDSYGRVNVNADTDGEISYTGPMTVL VNRYSASASEIFAAAMQDYGRAVILGENSFGKGTVQQHRSLNHIYDLFDK PLGHVQYTIQKFYRINGGSTQNLGVVPDIAFPTAIDPKDTGESVEDNALP WDSIKAADYAKTNQIAETIEPLAKKHVERIKTDEEFGFIQEDIARYKAEK DITSISLNKKVREKESDDADARRLTRVNERQKLLGKEEFKTLDDIPKDYE VPDAYLDEAVSITIDLALMNQKK >VF0199 hypothetical protein MLFFDNLHPSRIIVGEQSERAQVFADLLVEGAIKENIEVLLTNSTEAEAV KLFSNTYLAMRVAYFNELDSYAEAHGLDARQIIEGVGLDPRIGNHYNNPS FGYGGYCLPKDTKQLLANYQEVPNNIIGAIVDANRTRKDFVAESIMKRNP KVVGIYRLIMKAGSDNFRASSIQGIMKRLKAKGIEVVVYEPVLKEADFFN SRVIEDLAEFKQVSDVIVSNRMMEELSDVESKVYTRDLFGSD >VF2405 curli production assembly/transport component CsgG precursor MKYSIYYLFILLLAGCSNSIDIPETSESPTLMQRGANYIDLISLPKPQGK IFVSVYDFRDQTGQYKPQPNSNFSTAVPQGGTALLTMALLDSEWFYPLER QGLQNLLTERKIIRAAQKKQESISNHGSTLPSLLSANVMIEGGIVAYDSN IKTGGAGARYLGIGGSGQYRADQVTVNIRAVDVRSGKILTSVTTSKTILS YEVSAGAFRFVDYKELLEVELGYTNNEPVNIALMSAIDSAVIHLIVKGVQ QGLWRPANLDTRNNPIFKKYASETNQIL >VF2426 UDP-N-acetylenolpyruvoylglucosamine reductase MQILLNKTLKPYNSFSVNESADLIIQADSIQDLIDIWSDKKYTDMTKLPL GRGSNTLFCNHFNGVVVLNRLFGKSVTETDTDYLLKISSGEDWPALVEWC VDNGFAGIENLAMIPGCAGSAPIQNIGAYGLELKDICESVEYLDLETLQI KTLKNSECLFGYRESIFKHELKDRCIITAITLRLNKQWQPVLAYGPLSDL RNSKTTPKNVFDKICEIRSKKLPDPNVIGNAGSFFKNPVISEEHYLALCE TYPNLPAYDVTEGKKIAAGWLIDNAGLKGFKINGAQVHQEQALVLINTGT ATSEDILELANHVKNSVLDMYDIELEHEVRFYLNGEESFLSELFDERTH >VF0299 outer membrane protein MTIPFRVVWVNQVSNTEKLLLEVEFGPGFRYQNPNLDEIDDDDLILPETV QEPIIRTNVRTSWKALSNLTLAGEVTVTAGHSNTRVDSEVSVTNNITEEI ALKIAQSQQYLDRVPPGLSNTDSVFSINLLFSF >VF0663 N-acetylneuraminate lyase MKKLTGLIAAPHTPFDSSNNVNFEEIDKIAKHLIKDGVKGIYVCGTTGEG IHCSVEERKAIAERWVSASNNQLDIIVHTGALSIIDTLELTRHADTLDIL ATSAIGPCFFKPGSVADLVEYCATIAAAAPSKGFYYYHSGMSGVNLNMEE FLIQADKHIPNLSGLKFNSGDLYEYQRCLRACDGKFDIPFGVDEHLPGAL AVGAKSAVGSTYNYAAPHFNSIIEAFNRGDQEAVFNKMTNVIELIRVLVD FGGVAAGKVAMELHDINAGDPRLPLMPLTAEQKVTVATRMRNAGFIQ >VF0722 putative lipoprotein MKKVIIALSALFLAACSAPSDPQLDIQPKASSNAHQIVDGIKLTLDSSDL RTAQYVAVIDNGRQNVQPIHAKQNLRVTLEDALSSQLKTQGFVITVDSDN TLRLDIIEALVSVQHSLMSNEIKTQVKLQITAETPKGKFVKTYNGVSEKT GSMSADNQDIEQVLNDLLNAVLDKIAVDEELQTYIKGNF >VF0171 hypothetical protein MEWSDFSDDYDMLFCDSAVAKSIKQDIYVNKLSRIKSIVKVLFLFFRKNK CIDFKYNGINNLYVLESMTPSNFKTINPIFELDKSSKLIIVTTPVFQRID NVRYRGNLFNIDDYTFVNIGDFINSLHFCRRFNNKFRFVNIFQLIFLYLR ASSLNNVLNELFSNVKCNNIILTNDTLGLSNLIVQNSRVFNIKNYVLQHG LPTKFYFPTSADNYIVWGRRFVSEFKNKGARSKLYSLGSPKVDEVMKYCF SDAKYNDFLKRYNISNNKKIFTYFSNSHAPELDKKVHEINIKLLNGLISH KDYHVCIKLHPSESMQFIKEVLQPYDGKYTIIDHEDDVYDLVKFSSYCAS IYSTLLIESMCLGTYTFQFNATKSHKIPDYSNGGGCVEINSFEQLELSLN ASNKNKILNQQLKYTENYFSNQGTSSEKILELIHERNCI >VF0558 soluble lytic murein transglycosylase MKYTQYKLGMMTALCIGMNVQVVDASPVDTWRAQYQEAKTLLNEKKYDEY KKVRAELDGYSLAPYLDYRELRMDLSSKTPDDIRLFKHNHQSLPIGNSLS YQYLVILGLNERWAEFIDYFPNEPSSKNLQCYYYQAKNKLGDKATAWKGA EQLWLTGSSVTYECDDLFQDWAEAGKLSDDLIIERMLLVYKARNNNLFSY LEKMLKADAAKEKAQHIVTLFNDPDLLESFSKSNKKTEFSKQLTLISMER EARKNPKKAIEILPDIAKKQLFTQEELVQVKRRIVSSIMSTESAELAQWR DKELAANPEDSFIERRIRVAIRAADWDDVSNWIEYLTPTAKNSLRWQFWT AQIESKEGEQDKADARLKKLLGQRNFYSVAAANILGEPIQYPMNTAPRNI KPIKDKYSVELARIKELIAIDEIPTAKSEWEYLLNRASKTEVKELASYAA QHRWHHFTVLATIKGRMWGYLSLRFPIAHQWWFNHYSKELGLDKVTLMSL SRQESALYAEAQSPVGARGLMQIMPATAKYTAKKIDYDKYEGVDSLNDVD VNIHIGSNYLKGLLDDYDGNRIFALAGYNAGPHRVKRWRAVSDEKLDAYA FIEAIPFKETRGYVQNILMFETYYRSLLGEKGAFLSEKELNLKY >VF0178 3-deoxy-manno-octulosonate cytidylyltransferase MNVKVVIPARYGSSRLPGKPLLTLLDKPVIWHVIERCKEAGIEQNDIFVA TDDQRIIDALRDESIQVVLTSSEHQSGTDRINEVAQIKGWDEDTIIVNVQ GDEPMIPYRLIQRIVSFTQLNPSYHITTAVVPLVSQDDFVNPNVVKAIIG YNGRALYFTRSPSPLNRDNSSDLSLAKRHIGIYAYRASALKQFCSYSEDE LEQYEKLEQLRALSHGMSIGATIFDGFVPHGIDTIDDYENIKKIMEENIL >VF2131 cell wall endopeptidase, family M23/M37 MILSKLTRIPVIHRILIGLCSAGIVVTIATIPDTVAPDSGFYKLTVGQTY PIEIRKEALISHEKNSLNQQLSWETHTVKSGESASVLFSRIGLGYSQLLK LTSSDKEIENQLTRLRPGDKLKFGFNQGQEIVQLIRPISKFETYRISKAG DGYIGLFEKQDIETQLNYTKATITSNFWNASIGAGLNPNQIMELAGIFGW DIDFALDIREGDNFKVLYEEKYVEGEYAGKGNIIAASFTNRGDTFTAIRN DKNGNFYEPNGRAMKKAFLRSPINFRYVSSNFNPRRLHPVTGQRKAHRGT DYVAPVGTPIWAAGDGVVDKAGYNQFNGNYVFIRHSNTYITKYLHMTKRY VRAGQRVKQGDTIGTLGGTGRVTGPHLHYEFLVNGVHKDARTVSLPQSKS LTGKDKKEFEVVAKERLKQLEQYGQFIVGNHPVINHE >VF0346 hypothetical protein MTKLPFISVIIKTYNEEAGIEKTISSIKKNMGVYPHKIIVADSLSTDNTQ DIATKMDVTVVSLTEPEDRCCGVGHQLGYLYSEGDFLLLLDGDMELESGF IEQGVSFLLENPQYAGVAGSVEMDDVDSYEFKSRKQRLHQIYPIGDCSHL GGGGLYRKTAIDEIDYLTNRNLHAYEESELGMRLTHAGYKLHRLDVPYFF HTSYTMSSLALMKHRWKGGYLFAPGELVKGAFGTPLFSHALKTIKNEAIF AVYLFILFASLLSFNPILIGATSLPLFAFIGLKTIKNRSIRDALQSVLNL SVFAAGLIKGLFIPLKDPKTPPPHTVINEGKK >VF2206 UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase MMQLSELLLPWCDLNQSVAISSMTLDSRQVSPGCLFVAIKGHAVDGRQFI SSAIEQGAVAVIADADKENIAGTVKVIDNAIVVYIDSLYTQLSAIAGAFY QADKRNMQLVGITGTNGKTTISQIIAQWTTLLEQPAAVMGTTGNGLLSDL KPALNTTGSPIEIQQTLTELENIGAKLTALEVSSHGLVQGRVNALSFDAA VFTNLSRDHLDYHGDMANYAEAKKLLFTSHRPKNSIINGDDQVGCQWLKE MPHAVAVSLNEENISFHSGKKVFATSVVYSTEGIKLSISSDWGNVAFSVP LIGAFNASNILVAFAALLSLGYDIQALAQTASQLNAVIGRMELFATDNKA KVVVDYAHTPDALDKALQALRVHCEGKLWCIFGCGGDRDTGKRPIMASIV EQQADAIILSDDNPRSEEPSLITDDMLVGLKNAESAHVIHDRFEACQFAL SQANENDIILLAGKGHEDYQVLADKTVHYSDRETAQTLLGLQS >VF0197 UDP-N-acetylglucosamine 4,6-dehydratase MQFLQPIWSMPRPLKRLVSIVVDILFIVFAFWAAFATRLDGIEIYMQDVS YWKLLAVLIPCTLLVFTKSGLYRAILRYLSLHAVLSICISAIISSAFIVF ISYFNYLYMPRSIPVIYATYLVMLCGGSRLIVRVLVSDLLGKQKKKVLIY GAGSAGLQLANMLRQGKEFHPIAFIDDDRKKHKTTMQGITIYRPKYLERL IKKHCISTVLLAVPSASQVQKKVIIESLAKLHVEVLTIPNLDDLVNGKLS IGQLKEVSIDDLLGRVAVTPQAELMEANIKDKVVMVTGAGGSIGSELCRQ IILNKPTTLVLFELSEFSLYQIEHELSQIIANQQLSINVVPLLGSVQRLN RLAATMKAFKVQTVYHAAAYKHVPLVEYNVVEGVRNNIFGTNYAAQAAIE AKVESFVLISTDKAVRPTNVMGTTKRVAELGLQALAQVENAKPNGTRFCM VRFGNVLGSSGSVIPLFKKQIAQGGPITLTHKDITRYFMTIPEAAQLVIQ AGAMGKGGDVFVLDMGESVKIADLARNLIHLSGLEVRSDENPDGDIEIRC TGLRPGEKLYEELLIGDNVGKTAHERIMTANEEFLPLNEYNQLLDDLDTA CHNFDHATIRQLLIDAPTGFAPVDGIGDLVWKAEQ >VF0342 UTP--glucose-1-phosphate uridylyltransferase MIKKCLFPAAGYGTRFLPATKSMPKEMMPVVNKPLIEYGVEEAINAGMDG MCIVTGRGKHSLMDHFDKNYELEHQISGTNKEELLEDVRELIDSAHFTYI RQREMKGLGHAILTGRELVGDEPFAVVLADDLCVNEEQGVLAQMVALYKQ FRCSIVAVEEVPDNETHKYGVISGEMIKDDLYRVDNMVEKPEPGTAPSNL AIIGRYILTPDIFELIEQTEPGKGGEIQITDALLKQAQSGCVLAYKFKGK RFDCGSVEGYIEATNHCYENIYLKDKKSSELAKKVTGKK >VF0167 Glucose-1-phosphate thymidylyltransferase MKGIVLAGGSGTRLYPLTRGVSKQLLPIYDKPMVFYPISTLMLAGIKDIL IITTPEDNAGFKRLLGDGSDFGINLEYAIQPSPDGLAQAFIIGEEFIGDD SVCLVLGDNIFYGQSFGRTLRKAAARDYGASVFGYHVKDPERFGVVEFDK DYKALSIEEKPENPKSNWAVTGLYFYDNRVVSFAKKVEPSHRGELEITSI NQMYLNDGSLNVELLGRGFAWLDTGTHESLHEASSFVQTIENVQGLKVAC LEEIAWSQGWLSDEKVYEIAKPMLKNDYGKYLVSLLDNETLRSSLQANK >VF0420 membrane-bound lytic murein transglycosylase C precursor MKKIILIASTCLLLTSCSRESIESTFGVNYDTTNRFAKNLAPLPGQFTKD IKALDSLISSFNGNIEKRWGKKNLVTAGKRSYVKYTDGYLSRSQVDFTNG RVTVRNGCWY >VF2068 lipoprotein NlpD MRKMIINLISIRLWLMAAVVSLLLSGCSMGPHRPAPVSSVNSSSSAYNGA ERGSYRGSYYTVEKGDTLYFISYVTNKDVKELIAYNELKAPYMIHPGQKI KLWGPKYIAPAYGSDGHSVTPSNSSSSSTATAVAVVPVATNKPAPKPKPT TTSAKKTSSVQKESTKKVENSKPKEYVNSNKTITSSKPKPVAKPKPTPKP KPKPVQQKSDKVDSWLWPTKGRIIAKFSTGDQGNKGIDIAGQRGQDIIST AKGTVVYAGNALRGYGNLIIIKHNDDYLSAYAHNEALFVKEGQNVTAGQK IASMGSSSTSSVRLHFEIRFRGKSVNPQRYLP >VF0191 UDP-N-acetylglucosamine 4,6-dehydratase MFKDKILLITGGTGSFGNAVLDRFLETDIKEIRIFSRDEKKQDDMRKKYN SPKLKFYIGDVRDYNSILSASRGVDFVFHAAALKQVPSCEFHPMEAVKTN VLGTENVLEACIANEVSRVVCLSTDKAVYPINAMGISKAMMEKVIVAKSR NVDPNKTVISTTRYGNVMASRGSVIPLFLRQIMSGDAITITDPNMTRFMM TLNDAVDLVLHAFIYGINGDIFVQKAPAATIDVLVQALKAITSKPEHEVN VIGTRHGEKLYEALCSREEMFVAEDQGGYYRIPSDNRDLNYSQYVEEGEQ DLSTIEDYNSHNTDRLDVDGMIELLHKLDFIADIEAGSLIVPEGV >VF0149 glycosyltransferase MKIALVMVHGRVHGHVGGAPRVFFDMANHLSFEGHEVLAVYNDSKEGSPY YEVTNKVNLKNLALPIKFKGLWLYKAFREVIRSFAKLFNTDLRLNPVTKK NQKRVGLALKSLIDDFKPDVTISYNVSDLVSLSYIEWKARNSIVMCHTDP KRVYKGLANYERSIWQGADFIQVLLASYKDYLSKVINTNIEVIGNVVIEH DEVNDLSAFRIIYLARIEKNKQQHLLIEAINKIPLNVRLGWQVVLYGSCN DTEYSEFLINKINSYNLSDVIKLKGPTGKPFEELLNSSICAFPSAFEGFP LALTEAMSLGLPCIGFQSCSGVNELLINNYNGFLVKGVEEFALQLEVLMK SKERRSLMGSKARDSIECYSKESIYKKWKALIENKNVIV >VF2523 periplasmic component of efflux system MKKWTFFMLLLALLLFGSVIGFNMFKQQKIAEYMANRPEAEFPVTVETVE PTLWTPTIEAIGFIEPNQGVTLTTEVNGIIDKISFDSGSQVKKGQVLVSL DSKVEKANLKSTQARLPAAEAKYKRYKGLYKKGSISKEAYDEAEANYLSL AADIESMKASIDRREIKAPFSGVIGIRNVYLGQYLQPSTDIVRLEDTSVM RLRFTVPQTDISKINIGQEIDISVDSYPEDTFRGSISAIEPAVNIQSGLI EVQADIPNNGGKLRSGMFAQAKIILPTLENQVVIPQTAITFTLYGDNVYI VSEKDGVKRVQQHVVKVGERSKDIAHILEGVKAGDMVVTTGQVRLSNDAK VRIVESNATTPPAETPML >VF0459 prolipoprotein diacylglyceryl transferase MSQGYLNFPHIDPVLIEIGPLAVRWYGLMYLFGFMFALWLANKRADKPNS GWTRDQVSDLLFAGFLGVVIGGRVGYVLFYNFGYFLDNPLYLFEVWTGGM SFHGGLLGVISAMLWYGYKNNRSFFTIADFVAPLVPFGLGAGRLGNFMNG ELWGRVTDVPWAMVFPTGGPFPRHPSQLYEFALEGVVLFLILNWFIRKPR PLGTVSGLFLFGYGTFRFLVEYVRQPDAQLGLFGDWISMGQILSLPMVIG GLLMMLWAFKRNLYPSIEQPQSTTKKK >VF1183 acriflavin resistance periplasmic protein MQRLMKLSLLSSTLLLTACNPAPTETVVEIPNVVIKDINSNGVSDRLYLP AVATAADRSHLSFRLSGEIKELNIKAGEIVKKGQVLAVLDKTDYNIDVDN ARARYNVANSQYKRSKPLVDKGLLAKSQFDELAAQRQIALADLELAKLRL SFTELKAPIDGVISRVSVEQFENIQVGQQIFNINNRDAVDIIVQVPDKLY AKQPNKEIIESIKATVRLDSGESYSARIKEYTTEPDPDSGAYLVTLTMPM PEDQFILDGMAVEVATSESEIRLSTQAGMVIPIEAIFNEDGDTIDLAEKY VWLVDENNTVKKQKVVTTKATSSGLRVVEGLSTGDRIVIAGVSRLRDGMS VNVINAEEKK >VF0180 undecaprenyl-phosphatealpha-N-acetylglucosaminephosphotransferase MINAYLFVFLVSFISLFIMRKVAKRIGLVDKPNERKHHKGVIPLIGGISI FTTLCIGLLLFLPVTETLLMYLACAAVLVVLGAFDDYFDVSFKIRLIVQT GISLVIIFAGGHSLHNLGFLMGSETIMLSSAVSGFITILGVIGAINAFNM VDGIDGLLGGLASVTFAALATVFYYSGNDYLAHVCGLIVIAMVPYIMLNL GFPLGRRFKVFMGDAGSMFIGFTVVWMLIRGSQEPAVIAFKPVTALWLIA IPLMDMATIMIRRVRKGQSPFKPDREHLHHICQRLGLSSYMTLFLICTVA LICAFFGIWADLNGVSESVMFFSFLALFGVYFMTISYIWRITTFVHKLFG KRMSVQLQAEISK